[
  {
    "id": 253768,
    "drug": {
      "current_status": "MARKETED",
      "id": 53497,
      "drug_code": 95443,
      "updated_date": "2025-12-03T00:33:26-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262602,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466120",
      "brand_name": "CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752001"
    },
    "created_date": "2025-04-01T12:37:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466120",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2025-05-02T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253771,
    "drug": {
      "current_status": "MARKETED",
      "id": 29434,
      "drug_code": 91453,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260682,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02430126",
      "brand_name": "ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2025-04-01T12:40:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430126",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2025-04-11T00:00:00-04:00",
    "estimated_end_date": "2025-06-13T00:00:00-04:00",
    "actual_start_date": "2025-04-09T00:00:00-04:00",
    "actual_end_date": "2025-06-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-14T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ALTERNATE PACK SIZE AVAILABLE",
    "fr_comments": "ALTERNATE PACK SIZE AVAILABLE",
    "en_drug_brand_name": "ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram (Oxalate d'escitalopram)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253774,
    "drug": {
      "current_status": "MARKETED",
      "id": 21268,
      "drug_code": 83669,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257536,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351420",
      "brand_name": "FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101944002"
    },
    "created_date": "2025-04-01T12:41:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351420",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2025-06-13T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-06-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-14T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ALTERNATE PACK SIZE AVAILABLE",
    "fr_comments": "ALTERNATE PACK SIZE AVAILABLE",
    "en_drug_brand_name": "FUROSEMIDE",
    "en_drug_common_name": "FUROSEMIDE",
    "fr_drug_brand_name": "FUROSEMIDE",
    "fr_drug_common_name": "FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253778,
    "drug": {
      "current_status": "MARKETED",
      "id": 30702,
      "drug_code": 92757,
      "updated_date": "2025-05-15T02:34:54-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261285,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443015",
      "brand_name": "GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660002"
    },
    "created_date": "2025-04-01T12:44:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443015",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2025-06-13T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-06-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE ER",
    "fr_drug_brand_name": "GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE ER",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "Galantamine (Bromhydrate de galantamine)",
    "drug_strength": "8MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253781,
    "drug": {
      "current_status": "MARKETED",
      "id": 24926,
      "drug_code": 87443,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259017,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388898",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2025-04-01T12:46:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388898",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2025-04-18T00:00:00-04:00",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-21T00:00:00-04:00",
    "actual_end_date": "2025-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T05:00:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253784,
    "drug": {
      "current_status": "MARKETED",
      "id": 22706,
      "drug_code": 85244,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258184,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367602",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2025-04-01T12:49:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367602",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2025-04-25T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-25T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253789,
    "drug": {
      "current_status": "MARKETED",
      "id": 21822,
      "drug_code": 84201,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257795,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356899",
      "brand_name": "RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332007"
    },
    "created_date": "2025-04-01T12:52:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356899",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-05-09T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-06T05:00:22-04:00",
    "status": "resolved",
    "en_comments": "ALTERNATE PACK SIZE AVAILABLE",
    "fr_comments": "ALTERNATE PACK SIZE AVAILABLE",
    "en_drug_brand_name": "RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone (Tartrate de rispéridone)",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253801,
    "drug": {
      "current_status": "MARKETED",
      "id": 24476,
      "drug_code": 87098,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258840,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385341",
      "brand_name": "METFORMIN FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2025-04-01T13:24:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385341",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2025-03-31T00:00:00-04:00",
    "estimated_end_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-24T17:00:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METFORMIN FC",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "METFORMIN FC",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253804,
    "drug": {
      "current_status": "MARKETED",
      "id": 4268,
      "drug_code": 20162,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252679,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252678,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02187086",
      "brand_name": "BREVICON 0.5/35 TABLETS (21-DAY PACK)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82465",
      "number_of_ais": "2",
      "ai_group_no": "0210010001"
    },
    "created_date": "2025-04-01T13:33:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187086",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "actual_start_date": "2025-04-11T00:00:00-04:00",
    "actual_end_date": "2025-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-31T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BREVICON 0.5/35 TABLETS (21-DAY PACK)",
    "en_drug_common_name": "BREVICON",
    "fr_drug_brand_name": "Brevicon 1x21",
    "fr_drug_common_name": "Brevicon",
    "en_ingredients": "NORETHINDRONE\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Noréthindrone\r\nÉthinylestradiol",
    "drug_strength": "0.5MG\r\n0.035MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253826,
    "drug": {
      "current_status": "MARKETED",
      "id": 30180,
      "drug_code": 92226,
      "updated_date": "2025-12-03T00:32:44-05:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8261025,
          "ingredient": {
            "id": 3656,
            "ingredient_code": 20592,
            "en_name": "LIRAGLUTIDE",
            "fr_name": "Liraglutide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02437899",
      "brand_name": "SAXENDA",
      "brand_name_fr": "",
      "descriptor": "3ML MULTIDOSE PREFILLED PEN. EACH PEN DELIVERS DOSES OF 0.6MG, 1.2MG, 1.8MG, 2.4MG AND 3MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152718001"
    },
    "created_date": "2025-04-01T14:35:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437899",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "A10BJ",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2025-10-01T00:00:00-04:00",
    "actual_end_date": "2025-07-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-07-08T14:30:57-04:00",
    "status": "avoided_shortage",
    "en_comments": "Product available.",
    "fr_comments": "Produit disponible.",
    "en_drug_brand_name": "SAXENDA",
    "en_drug_common_name": "Liraglutide injection",
    "fr_drug_brand_name": "SAXENDA",
    "fr_drug_common_name": "Injection de liraglutide",
    "en_ingredients": "LIRAGLUTIDE",
    "fr_ingredients": "Liraglutide",
    "drug_strength": "6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "EA",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253853,
    "drug": {
      "current_status": "MARKETED",
      "id": 19506,
      "drug_code": 80802,
      "updated_date": "2025-05-15T02:32:20-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256815,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02322579",
      "brand_name": "SANDOZ FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2025-04-01T15:10:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02322579",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "discontinuation_date": "2025-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2025-04-02T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "SANDOZ FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253860,
    "drug": {
      "current_status": "MARKETED",
      "id": 63376,
      "drug_code": 95822,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262832,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02469421",
      "brand_name": "SANDOZ HYDROCORTISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106344008"
    },
    "created_date": "2025-04-01T15:13:35-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02469421",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2025-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2025-04-02T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ HYDROCORTISONE",
    "en_drug_common_name": "HYDROCORTISONE",
    "fr_drug_brand_name": "SANDOZ HYDROCORTISONE",
    "fr_drug_common_name": "HYDROCORTISONE",
    "en_ingredients": "HYDROCORTISONE",
    "fr_ingredients": "Hydrocortisone",
    "drug_strength": "2.5%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "225G",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253873,
    "drug": {
      "current_status": "MARKETED",
      "id": 7620,
      "drug_code": 50442,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253356,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231135",
      "brand_name": "PMS-IPRATROPIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643003"
    },
    "created_date": "2025-04-01T15:25:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231135",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2025-08-18T00:00:00-04:00",
    "actual_start_date": "2025-03-31T00:00:00-04:00",
    "actual_end_date": "2025-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-19T13:47:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IPRATROPIUM",
    "en_drug_common_name": "IPRATROPIUM",
    "fr_drug_brand_name": "PMS-IPRATROPIUM",
    "fr_drug_common_name": "IPRATROPIUM",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "125MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20x2ml & 10x2ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 253876,
    "drug": {
      "current_status": "MARKETED",
      "id": 19280,
      "drug_code": 80544,
      "updated_date": "2025-12-03T00:31:23-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256743,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02319993",
      "brand_name": "PMS-OXYCODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552001"
    },
    "created_date": "2025-04-01T15:27:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319993",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2025-04-28T00:00:00-04:00",
    "actual_start_date": "2025-03-31T00:00:00-04:00",
    "actual_end_date": "2025-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-25T15:00:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OXYCODONE",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "PMS - OXYCODONE",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253879,
    "drug": {
      "current_status": "MARKETED",
      "id": 4050,
      "drug_code": 19762,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252569,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02208237",
      "brand_name": "PMS-SALBUTAMOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82058",
      "number_of_ais": "1",
      "ai_group_no": "0108887001"
    },
    "created_date": "2025-04-01T15:30:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02208237",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2025-05-21T00:00:00-04:00",
    "actual_start_date": "2025-03-31T00:00:00-04:00",
    "actual_end_date": "2025-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-21T13:05:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SALBUTAMOL",
    "en_drug_common_name": "SALBUTAMOL",
    "fr_drug_brand_name": "pms-SALBUTAMOL",
    "fr_drug_common_name": "SALBUTAMOL",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol (Sulfate de salbutamol)",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20X2.5mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253882,
    "drug": {
      "current_status": "MARKETED",
      "id": 14124,
      "drug_code": 74163,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255100,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02256428",
      "brand_name": "PMS-SUMATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238007"
    },
    "created_date": "2025-04-01T15:31:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256428",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2025-05-08T00:00:00-04:00",
    "actual_start_date": "2025-03-31T00:00:00-04:00",
    "actual_end_date": "2025-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-12T19:27:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SUMATRIPTAN",
    "en_drug_common_name": "SUMATRIPTAN",
    "fr_drug_brand_name": "pms-SUMATRIPTAN",
    "fr_drug_common_name": "SUMATRIPTAN",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan (Succinate de sumatriptan)",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253899,
    "drug": {
      "current_status": "MARKETED",
      "id": 3488,
      "drug_code": 18778,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252381,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02171899",
      "brand_name": "TIMOPTIC-XE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81052",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2025-04-01T18:29:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02171899",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2025-04-01T00:00:00-04:00",
    "estimated_end_date": "2025-04-25T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-04-25T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TIMOPTIC-XE",
    "en_drug_common_name": "timolol maleate",
    "fr_drug_brand_name": "TIMOPTIC‐XE",
    "fr_drug_common_name": "Maléate de timolol",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "Timolol (Maléate de timolol)",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Solution (à libération prolongée)",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253960,
    "drug": {
      "current_status": "MARKETED",
      "id": 3710,
      "drug_code": 19200,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252459,
          "ingredient": {
            "id": 1536,
            "ingredient_code": 11254,
            "en_name": "CEFOXITIN",
            "fr_name": "Céfoxitine (Céfoxitine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02128187",
      "brand_name": "CEFOXITIN FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81491",
      "number_of_ais": "1",
      "ai_group_no": "0113134002"
    },
    "created_date": "2025-04-02T19:56:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02128187",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2025-04-30T00:00:00-04:00",
    "actual_start_date": "2025-03-30T00:00:00-04:00",
    "actual_end_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-08T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Product now available",
    "en_drug_brand_name": "CEFOXITIN FOR INJECTION",
    "en_drug_common_name": "CEFOXITIN FOR INJECTION",
    "fr_drug_brand_name": "CEFOXITIN FOR INJECTION",
    "fr_drug_common_name": "CEFOXITIN FOR INJECTION",
    "en_ingredients": "CEFOXITIN",
    "fr_ingredients": "Céfoxitine (Céfoxitine sodique)",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253963,
    "drug": {
      "current_status": "MARKETED",
      "id": 25644,
      "drug_code": 88053,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259262,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395444",
      "brand_name": "TEVA-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2025-04-02T19:58:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-04-11T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-10T15:17:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "TEVA-QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253968,
    "drug": {
      "current_status": "MARKETED",
      "id": 101018,
      "drug_code": 99489,
      "updated_date": "2020-10-02T23:55:50-04:00",
      "company": {
        "id": 7815,
        "created_date": "2018-05-03T02:30:12-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 17067,
        "mfr_code": "",
        "name": "AVIR PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265610,
          "ingredient": {
            "id": 3000,
            "ingredient_code": 12945,
            "en_name": "BIVALIRUDIN",
            "fr_name": "Bivalirudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02505517",
      "brand_name": "BIVALIRUDIN INJECTION",
      "brand_name_fr": "BIVALIRUDINE INJECTABLE",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148342002"
    },
    "created_date": "2025-04-02T20:37:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02505517",
    "company_name": "AVIR PHARMA INC.",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2025-04-02T00:00:00-04:00",
    "estimated_end_date": "2025-04-18T00:00:00-04:00",
    "actual_end_date": "2025-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-04-24T05:00:13-04:00",
    "status": "resolved",
    "en_comments": "We still have inventory, but only shortdated inventory",
    "fr_comments": "Nous avons de l'inventaire, mais seulement de l'inventaire avec courte durée de vie",
    "en_drug_brand_name": "BIVALIRUDIN INJECTION",
    "en_drug_common_name": "Bivalirudin Injectable 250mg/50mL 10vials",
    "fr_drug_brand_name": "Bivalirudin Injectable",
    "fr_drug_common_name": "Bivalirudin Injectable 250mg/50mL 10vials",
    "en_ingredients": "BIVALIRUDIN",
    "fr_ingredients": "Bivalirudine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253975,
    "drug": {
      "current_status": "MARKETED",
      "id": 4640,
      "drug_code": 2367,
      "updated_date": "2025-12-03T00:30:20-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250403,
          "ingredient": {
            "id": 1744,
            "ingredient_code": 8003,
            "en_name": "PERPHENAZINE",
            "fr_name": "Perphénazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335126",
      "brand_name": "PERPHENAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49062",
      "number_of_ais": "1",
      "ai_group_no": "0106175005"
    },
    "created_date": "2025-04-03T11:56:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335126",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05AB",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2025-04-02T00:00:00-04:00",
    "estimated_end_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-20T18:27:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PERPHENAZINE",
    "en_drug_common_name": "PERPHENAZINE",
    "fr_drug_brand_name": "PERPHENAZINE",
    "fr_drug_common_name": "PERPHENAZINE",
    "en_ingredients": "PERPHENAZINE",
    "fr_ingredients": "Perphénazine",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253982,
    "drug": {
      "current_status": "MARKETED",
      "id": 14682,
      "drug_code": 74973,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255279,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02264307",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2025-04-03T14:53:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264307",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-02T00:00:00-04:00",
    "actual_end_date": "2025-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-14T05:00:10-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays, we have encountered a supply interruption on our Heparin Sodium Injection, USP 10 000 USP units/mL MD Vial 5 mL effective April 2, 2025, until May 23, 2025.",
    "fr_comments": "Fresenius Kabi Canada Ltée a le regret de vous aviser qu’en raison de retards de production, nous avons rencontré une interruption d’approvisionnement sur notre présentation d’Héparine sodique injectable, USP 10 000 unités USP/mL, fiole DM, 5 mL du 2 avril 2025 au 23 mai 2025.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "HEPARIN SODIUM INJECTION, USP",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "5mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253985,
    "drug": {
      "current_status": "MARKETED",
      "id": 25294,
      "drug_code": 87773,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259168,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02392453",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE. 0.5ML SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2025-04-03T14:55:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392453",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-06-04T00:00:00-04:00",
    "actual_start_date": "2025-04-30T00:00:00-04:00",
    "actual_end_date": "2025-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-02T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be extending the backorder on our Heparin Sodium Injection, USP 10 000 USP units/mL, 0.5 mL Vial until June 4, 2025.",
    "fr_comments": "Fresenius Kabi Canada a le regret d’annoncer qu’en raison de retards d’expédition, nous sommes contraints de prolonger la période de commande en souffrance pour notre présentation d’Héparine sodique injectable, USP 10 000 unités USP/mL, fiole 0.5 mL jusqu’au 4 juin 2025.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "HEPARIN SODIUM INJECTION, USP",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "0.5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 253988,
    "drug": {
      "current_status": "MARKETED",
      "id": 66450,
      "drug_code": 97315,
      "updated_date": "2025-05-15T02:37:04-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263719,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02482746",
      "brand_name": "MORPHINE SULFATE INJECTION, USP",
      "brand_name_fr": "SULFATE DE MORPHINE INJECTABLE, USP",
      "descriptor": "SINGLE USE VIAL, PRESERVATIVE FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545001"
    },
    "created_date": "2025-04-03T14:57:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02482746",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2025-07-18T00:00:00-04:00",
    "actual_start_date": "2025-04-25T00:00:00-04:00",
    "actual_end_date": "2025-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-23T05:00:18-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Morphine Sulfate Injection, USP 10 mg / mL SD Vial 1 mL effective April 25, 2025, until July 18, 2025.",
    "fr_comments": "Fresenius Kabi Canada Ltée a le regret de vous aviser qu’en raison de retards de production, une interruption d’approvisionnement va toucher sa présentation de Sulfate de morphine injectable, USP 10 mg/mL, fiole, 1 mL du 25 avril 2025 au 18 juillet 2025.",
    "en_drug_brand_name": "MORPHINE SULFATE INJECTION, USP",
    "en_drug_common_name": "MORPHINE SULFATE INJECTION, USP",
    "fr_drug_brand_name": "Sulfate de morphine injectable, USP",
    "fr_drug_common_name": "Sulfate de morphine injectable, USP",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254001,
    "drug": {
      "current_status": "MARKETED",
      "id": 101422,
      "drug_code": 99344,
      "updated_date": "2021-02-08T05:56:43-05:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265522,
          "ingredient": {
            "id": 3736,
            "ingredient_code": 20883,
            "en_name": "ABIRATERONE ACETATE",
            "fr_name": "Acétate d'abiratérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02503980",
      "brand_name": "MAR-ABIRATERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152948001"
    },
    "created_date": "2025-04-03T16:43:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02503980",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "L02BX",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2025-04-04T00:00:00-04:00",
    "estimated_end_date": "2025-05-30T00:00:00-04:00",
    "actual_start_date": "2025-04-04T00:00:00-04:00",
    "actual_end_date": "2025-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-02T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-ABIRATERONE",
    "en_drug_common_name": "MAR-Abiraterone 250mg",
    "fr_drug_brand_name": "MAR-Abiraterone",
    "fr_drug_common_name": "MAR-Abiraterone 250mg",
    "en_ingredients": "ABIRATERONE ACETATE",
    "fr_ingredients": "Acétate d'abiratérone",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254004,
    "drug": {
      "current_status": "MARKETED",
      "id": 30176,
      "drug_code": 92223,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8261023,
          "ingredient": {
            "id": 418,
            "ingredient_code": 8344,
            "en_name": "CEFTAZIDIME",
            "fr_name": "Ceftazidime (Ceftazidime pentahydratée)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02437864",
      "brand_name": "CEFTAZIDIME FOR INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "I.V. INFUSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116900009"
    },
    "created_date": "2025-04-03T17:27:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437864",
    "company_name": "STERIMAX INC",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2025-07-15T00:00:00-04:00",
    "estimated_end_date": "2025-11-28T00:00:00-05:00",
    "actual_end_date": "2025-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-03T16:19:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTAZIDIME FOR INJECTION BP",
    "en_drug_common_name": "CEFTAZIDIME FOR INJECTION BP",
    "fr_drug_brand_name": "CEFTAZIDIME POUR INJECTION BP",
    "fr_drug_common_name": "CEFTAZIDIME POUR INJECTION BP",
    "en_ingredients": "CEFTAZIDIME",
    "fr_ingredients": "Ceftazidime (Ceftazidime pentahydratée)",
    "drug_strength": "6G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254013,
    "drug": {
      "current_status": "MARKETED",
      "id": 9450,
      "drug_code": 62794,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8253682,
          "ingredient": {
            "id": 1584,
            "ingredient_code": 1255,
            "en_name": "OCTREOTIDE",
            "fr_name": "Octréotide (Acétate d'octréotide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02239325",
      "brand_name": "SANDOSTATIN LAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121548007"
    },
    "created_date": "2025-04-03T18:57:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239325",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "H01CB",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "anticipated_start_date": "2025-04-08T00:00:00-04:00",
    "estimated_end_date": "2025-08-01T00:00:00-04:00",
    "actual_end_date": "2025-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-06T13:53:35-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation",
    "fr_comments": "Produit sur allocation",
    "en_drug_brand_name": "SANDOSTATIN LAR",
    "en_drug_common_name": "SANDOSTATIN LAR 30MG",
    "fr_drug_brand_name": "SANDOSTATIN LAR",
    "fr_drug_common_name": "SANDOSTATIN LAR 30MG",
    "en_ingredients": "OCTREOTIDE",
    "fr_ingredients": "Octréotide (Acétate d'octréotide)",
    "drug_strength": "30MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION, SUSTAINED-RELEASE",
    "drug_dosage_form_fr": "Poudre pour suspension, à libération prolongée",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 x 30 MG SYRINGE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254019,
    "drug": {
      "current_status": "MARKETED",
      "id": 9448,
      "drug_code": 62793,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8253681,
          "ingredient": {
            "id": 1584,
            "ingredient_code": 1255,
            "en_name": "OCTREOTIDE",
            "fr_name": "Octréotide (Acétate d'octréotide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02239324",
      "brand_name": "SANDOSTATIN LAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121548006"
    },
    "created_date": "2025-04-03T19:02:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239324",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "H01CB",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "anticipated_start_date": "2025-04-14T00:00:00-04:00",
    "estimated_end_date": "2025-07-17T00:00:00-04:00",
    "actual_end_date": "2025-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-06T13:52:41-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation",
    "fr_comments": "Produit sur allocation",
    "en_drug_brand_name": "SANDOSTATIN LAR",
    "en_drug_common_name": "SANDOSTATIN LAR 20MG",
    "fr_drug_brand_name": "SANDOSTATIN LAR",
    "fr_drug_common_name": "SANDOSTATIN LAR 20MG",
    "en_ingredients": "OCTREOTIDE",
    "fr_ingredients": "Octréotide (Acétate d'octréotide)",
    "drug_strength": "20MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION, SUSTAINED-RELEASE",
    "drug_dosage_form_fr": "Poudre pour suspension, à libération prolongée",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 x 20 MG SYRINGE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254027,
    "drug": {
      "current_status": "MARKETED",
      "id": 31282,
      "drug_code": 93496,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261598,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449145",
      "brand_name": "AURO-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555002"
    },
    "created_date": "2025-04-03T19:27:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449145",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2025-05-15T00:00:00-04:00",
    "actual_start_date": "2025-04-04T00:00:00-04:00",
    "actual_end_date": "2025-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T15:47:22-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "AURO-BETAHISTINE",
    "en_drug_common_name": "Auro-Betahistine 8mg Tab 100 Btl",
    "fr_drug_brand_name": "Auro-Betahistine 8mg Tab 100 Btl",
    "fr_drug_common_name": "Auro-Betahistine 8mg Tab 100 Btl",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bétahistine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254030,
    "drug": {
      "current_status": "MARKETED",
      "id": 99241,
      "drug_code": 95694,
      "updated_date": "2020-04-03T06:53:31-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8262760,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02468514",
      "brand_name": "DEXTROSE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102181001"
    },
    "created_date": "2025-04-03T20:30:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468514",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "actual_start_date": "2025-05-15T00:00:00-04:00",
    "actual_end_date": "2025-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-05T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ANSYR format will remain fully available.",
    "fr_comments": "Veuillez noter que le format ANSYR resterons disponibles.",
    "en_drug_brand_name": "DEXTROSE INJECTION USP",
    "en_drug_common_name": "DEXTROSE INJECTION USP",
    "fr_drug_brand_name": "DEXTROSE INJECTION USP",
    "fr_drug_common_name": "DEXTROSE INJECTION USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 X 50 ML LifeShield syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254035,
    "drug": {
      "current_status": "MARKETED",
      "id": 13188,
      "drug_code": 72643,
      "updated_date": "2025-12-03T00:30:55-05:00",
      "company": {
        "id": 604,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 6996,
        "mfr_code": "BEW08",
        "name": "BRACCO IMAGING CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11065 BOUL. L-H LAFONTAINE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VILLE D'ANJOU",
        "postal_code": "H1J 2Z4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254793,
          "ingredient": {
            "id": 3090,
            "ingredient_code": 12297,
            "en_name": "GADOBENATE DIMEGLUMINE",
            "fr_name": "Diméglumine de gadobénate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "529",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248302",
      "brand_name": "MULTIHANCE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149628001"
    },
    "created_date": "2025-04-03T21:13:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248302",
    "company_name": "BRACCO IMAGING CANADA",
    "atc_number": "V08CA",
    "atc_description": "MAGNETIC RESONANCE IMAGING CONTRAST MEDIA",
    "anticipated_start_date": "2025-06-30T00:00:00-04:00",
    "estimated_end_date": "2025-08-15T00:00:00-04:00",
    "actual_start_date": "2025-07-15T00:00:00-04:00",
    "actual_end_date": "2025-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-08-09T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "This MultiHance format has been received, released and shipped to Canadian customers",
    "fr_comments": "Ce format du produit MultiHance a ete recu, relache et expedie aux clients canadiens",
    "en_drug_brand_name": "MULTIHANCE",
    "en_drug_common_name": "Gadobenate Dimeglumine injection",
    "fr_drug_brand_name": "MultiHance",
    "fr_drug_common_name": "Diméglumine de gadobénate",
    "en_ingredients": "GADOBENATE DIMEGLUMINE",
    "fr_ingredients": "Diméglumine de gadobénate",
    "drug_strength": "529MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Box of 5 vials of 10ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254038,
    "drug": {
      "current_status": "MARKETED",
      "id": 13188,
      "drug_code": 72643,
      "updated_date": "2025-12-03T00:30:55-05:00",
      "company": {
        "id": 604,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 6996,
        "mfr_code": "BEW08",
        "name": "BRACCO IMAGING CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11065 BOUL. L-H LAFONTAINE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VILLE D'ANJOU",
        "postal_code": "H1J 2Z4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254793,
          "ingredient": {
            "id": 3090,
            "ingredient_code": 12297,
            "en_name": "GADOBENATE DIMEGLUMINE",
            "fr_name": "Diméglumine de gadobénate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "529",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248302",
      "brand_name": "MULTIHANCE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149628001"
    },
    "created_date": "2025-04-03T21:17:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248302",
    "company_name": "BRACCO IMAGING CANADA",
    "atc_number": "V08CA",
    "atc_description": "MAGNETIC RESONANCE IMAGING CONTRAST MEDIA",
    "anticipated_start_date": "2025-05-31T00:00:00-04:00",
    "estimated_end_date": "2025-08-15T00:00:00-04:00",
    "actual_start_date": "2025-06-13T00:00:00-04:00",
    "actual_end_date": "2025-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-08-09T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "This MultiHance format has been received, released and shipped to Canadian customers",
    "fr_comments": "Ce format du MultiHance a ete recu, relache et expedie a nos clients canadiens",
    "en_drug_brand_name": "MULTIHANCE",
    "en_drug_common_name": "Gadobenate Dimeglumine injection",
    "fr_drug_brand_name": "MultiHance",
    "fr_drug_common_name": "Diméglumine de gadobénate",
    "en_ingredients": "GADOBENATE DIMEGLUMINE",
    "fr_ingredients": "Diméglumine de gadobénate",
    "drug_strength": "529MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Box of 5 vials of 50ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254067,
    "drug": {
      "current_status": "MARKETED",
      "id": 14304,
      "drug_code": 74388,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255153,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8255152,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258692",
      "brand_name": "COSOPT PRESERVATIVE-FREE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2025-04-04T15:04:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258692",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2025-04-04T00:00:00-04:00",
    "estimated_end_date": "2025-06-26T00:00:00-04:00",
    "actual_start_date": "2025-04-04T00:00:00-04:00",
    "actual_end_date": "2025-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-06-19T14:19:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COSOPT PRESERVATIVE-FREE",
    "en_drug_common_name": "Dorzolamide and Timolol Ophthalmic Solution",
    "fr_drug_brand_name": "COSOPT",
    "fr_drug_common_name": "Collyre de dorzolamide et de timolol",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "Timolol (Maléate de timolol)\r\nDorzolamide (Chlorhydrate de dorzolamide)",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.2ml 60 Pipettes",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254081,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15016,
      "drug_code": 75449,
      "updated_date": "2025-12-03T01:23:44-05:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341398,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02269090",
      "brand_name": "TRUSOPT PRESERVATIVE-FREE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128558001"
    },
    "created_date": "2025-04-04T15:17:16-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02269090",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "discontinuation_date": "2024-11-20T00:00:00-05:00",
    "anticipated_discontinuation_date": "2024-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "zero supply remaining",
    "fr_supply_disruption_mitigation": "Zéro inventaire disponible  or  Aucun inventaire disponible",
    "en_discontinuation_comments": "There are 3 generic alternatives of dorzolamide 2% currently on the market",
    "fr_discontinuation_comments": "Il existe 3 alternatives génériques de dorzolamide 2% actuellement sur le marché",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-04T15:27:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TRUSOPT PRESERVATIVE-FREE",
    "en_drug_common_name": "Dorzolamide Hydrochloride Ophthalmic Solution",
    "fr_drug_brand_name": "Trusopt UD",
    "fr_drug_common_name": "Collyre de chlorhydrate de dorzolamide",
    "en_ingredients": "DORZOLAMIDE",
    "fr_ingredients": "Dorzolamide (Chlorhydrate de dorzolamide)",
    "drug_strength": "2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254124,
    "drug": {
      "current_status": "MARKETED",
      "id": 15398,
      "drug_code": 75966,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255512,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274205",
      "brand_name": "TEVA-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2025-04-04T15:45:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2025-06-20T00:00:00-04:00",
    "actual_start_date": "2025-04-03T00:00:00-04:00",
    "actual_end_date": "2025-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-19T15:42:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM 750MG FC TAB",
    "fr_drug_brand_name": "TEVA-LEVETIRACETAM 750MG FC TAB",
    "fr_drug_common_name": "LEVETIRACETAM 750MG FC TAB",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254127,
    "drug": {
      "current_status": "MARKETED",
      "id": 16428,
      "drug_code": 77228,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255860,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286823",
      "brand_name": "TEVA-SUMATRIPTAN DF",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238002"
    },
    "created_date": "2025-04-04T15:51:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286823",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2025-05-10T00:00:00-04:00",
    "actual_start_date": "2025-04-03T00:00:00-04:00",
    "actual_end_date": "2025-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-08T19:21:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUMATRIPTAN DF",
    "en_drug_common_name": "SUMATRIPTAN DF 50MG TAB",
    "fr_drug_brand_name": "TEVA-SUMATRIPTAN DF 50MG TAB",
    "fr_drug_common_name": "SUMATRIPTAN DF 50MG TAB",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan (Succinate de sumatriptan)",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254130,
    "drug": {
      "current_status": "MARKETED",
      "id": 11568,
      "drug_code": 68491,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254313,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244514",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "300MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2025-04-04T15:52:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244514",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02BF",
    "estimated_end_date": "2025-06-30T00:00:00-04:00",
    "actual_start_date": "2025-04-03T00:00:00-04:00",
    "actual_end_date": "2025-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-27T14:19:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 300MG CAPS",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 300MG CAPS",
    "fr_drug_common_name": "GABAPENTIN 300MG CAPS",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254133,
    "drug": {
      "current_status": "MARKETED",
      "id": 3312,
      "drug_code": 18421,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252306,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02158574",
      "brand_name": "TEVA-DOXYCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80679",
      "number_of_ais": "1",
      "ai_group_no": "0105569001"
    },
    "created_date": "2025-04-04T15:54:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02158574",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2025-08-20T00:00:00-04:00",
    "actual_start_date": "2025-04-03T00:00:00-04:00",
    "actual_end_date": "2025-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-08T16:52:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOXYCYCLINE",
    "en_drug_common_name": "DOXYCYCLINE 100MG FC TAB",
    "fr_drug_brand_name": "TEVA-DOXYCYCLINE 100MG FC TAB",
    "fr_drug_common_name": "DOXYCYCLINE 100MG FC TAB",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline (Hyclate de doxycycline)",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254136,
    "drug": {
      "current_status": "MARKETED",
      "id": 970,
      "drug_code": 12261,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251605,
          "ingredient": {
            "id": 356,
            "ingredient_code": 8450,
            "en_name": "AMPICILLIN",
            "fr_name": "Ampicilline (Ampicilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00872644",
      "brand_name": "AMPICILLIN SODIUM FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73331",
      "number_of_ais": "1",
      "ai_group_no": "0105872002"
    },
    "created_date": "2025-04-04T15:55:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00872644",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2025-10-10T00:00:00-04:00",
    "actual_start_date": "2025-04-03T00:00:00-04:00",
    "actual_end_date": "2025-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-10T16:39:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AMPICILLIN SODIUM FOR INJECTION, USP",
    "en_drug_common_name": "AMPICILLIN SODIUM INJ 250MG",
    "fr_drug_brand_name": "AMPICILLIN SODIUM INJ 250MG",
    "fr_drug_common_name": "AMPICILLIN SODIUM INJ 250MG",
    "en_ingredients": "AMPICILLIN",
    "fr_ingredients": "Ampicilline (Ampicilline sodique)",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 PK",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254139,
    "drug": {
      "current_status": "MARKETED",
      "id": 8276,
      "drug_code": 5646,
      "updated_date": "2025-05-15T02:30:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250793,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00613215",
      "brand_name": "TEVA-SPIRONOLACTONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61191",
      "number_of_ais": "1",
      "ai_group_no": "0106462001"
    },
    "created_date": "2025-04-04T15:56:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00613215",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03DA",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "estimated_end_date": "2025-07-31T00:00:00-04:00",
    "actual_start_date": "2025-04-03T00:00:00-04:00",
    "actual_end_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-08T13:06:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SPIRONOLACTONE",
    "en_drug_common_name": "TEVA-SPIRONOLACTONE 25MG TABS",
    "fr_drug_brand_name": "TEVA-SPIRONOLACTONE 25MG TABS",
    "fr_drug_common_name": "SPIRONOLACTONE 25MG TABS",
    "en_ingredients": "SPIRONOLACTONE",
    "fr_ingredients": "Spironolactone",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "UD 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 254156,
    "drug": {
      "current_status": "MARKETED",
      "id": 51713,
      "drug_code": 93840,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261774,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261773,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452006",
      "brand_name": "APO-EMTRICITABINE-TENOFOVIR",
      "brand_name_fr": "APO-EMTRICITABINE-TÉNOFOVIR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251568001"
    },
    "created_date": "2025-04-04T16:18:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452006",
    "company_name": "APOTEX INC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2025-05-02T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-02T20:11:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-EMTRICITABINE-TENOFOVIR",
    "en_drug_common_name": "EMTRICITABINE / TENOFOVIR",
    "fr_drug_brand_name": "APO-EMTRICITABINE-TENOFOVIR",
    "fr_drug_common_name": "EMTRICITABINE / TENOFOVIR",
    "en_ingredients": "EMTRICITABINE\r\nTENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Emtricitabine\r\nFumarate de ténofovir disoproxil",
    "drug_strength": "200MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254159,
    "drug": {
      "current_status": "MARKETED",
      "id": 56390,
      "drug_code": 96022,
      "updated_date": "2025-05-15T02:36:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262953,
          "ingredient": {
            "id": 3528,
            "ingredient_code": 20435,
            "en_name": "ARIPIPRAZOLE",
            "fr_name": "Aripiprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471116",
      "brand_name": "APO-ARIPIPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152514003"
    },
    "created_date": "2025-04-04T16:20:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471116",
    "company_name": "APOTEX INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-05-30T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-30T18:41:53-04:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 btl disponible",
    "en_drug_brand_name": "APO-ARIPIPRAZOLE",
    "en_drug_common_name": "ARIPIPRAZOLE",
    "fr_drug_brand_name": "APO-ARIPIPRAZOLE",
    "fr_drug_common_name": "ARIPIPRAZOLE",
    "en_ingredients": "ARIPIPRAZOLE",
    "fr_ingredients": "Aripiprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254162,
    "drug": {
      "current_status": "MARKETED",
      "id": 7552,
      "drug_code": 50280,
      "updated_date": "2025-12-03T00:30:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253339,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230999",
      "brand_name": "APO-DILTIAZ CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863006"
    },
    "created_date": "2025-04-04T16:21:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230999",
    "company_name": "APOTEX INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2025-04-18T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-17T13:58:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DILTIAZ CD",
    "en_drug_common_name": "DILTIAZ CD",
    "fr_drug_brand_name": "APO-DILTIAZ CD",
    "fr_drug_common_name": "DILTIAZ CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "240MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254165,
    "drug": {
      "current_status": "MARKETED",
      "id": 11788,
      "drug_code": 69269,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254376,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02245247",
      "brand_name": "APO-GLICLAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934001"
    },
    "created_date": "2025-04-04T16:22:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245247",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-23T19:09:52-04:00",
    "status": "resolved",
    "en_comments": "500 BTL available",
    "fr_comments": "500 btl disponible",
    "en_drug_brand_name": "APO-GLICLAZIDE",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "APO-GLICLAZIDE",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254169,
    "drug": {
      "current_status": "MARKETED",
      "id": 25426,
      "drug_code": 87869,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259212,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393476",
      "brand_name": "APO-RIZATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2025-04-04T16:24:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393476",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2025-04-25T00:00:00-04:00",
    "actual_start_date": "2025-04-01T00:00:00-04:00",
    "actual_end_date": "2025-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-11T19:52:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RIZATRIPTAN",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "APO-RIZATRIPTAN",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "Rizatriptan (Benzoate de rizatriptan)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254178,
    "drug": {
      "current_status": "MARKETED",
      "id": 30342,
      "drug_code": 92398,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261090,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439565",
      "brand_name": "NAT-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2025-04-04T18:22:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439565",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2025-04-11T00:00:00-04:00",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2025-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-03T17:17:03-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "NAT-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "NAT-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254185,
    "drug": {
      "current_status": "MARKETED",
      "id": 30038,
      "drug_code": 92093,
      "updated_date": "2025-05-15T02:34:38-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260934,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436604",
      "brand_name": "NAT-RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2025-04-04T18:27:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436604",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2026-12-31T00:00:00-05:00",
    "actual_start_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-07-03T17:12:41-04:00",
    "status": "active_confirmed",
    "en_comments": "Long Term Back Order",
    "fr_comments": "Commande en souffrance à long terme",
    "en_drug_brand_name": "NAT-RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "NAT-RIZATRIPTAN",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "Rizatriptan (Benzoate de rizatriptan)",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 UD BLS",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254190,
    "drug": {
      "current_status": "MARKETED",
      "id": 30040,
      "drug_code": 92094,
      "updated_date": "2025-05-15T02:34:38-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260935,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436612",
      "brand_name": "NAT-RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2025-04-04T18:29:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436612",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2026-12-31T00:00:00-05:00",
    "actual_start_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-07-03T17:12:16-04:00",
    "status": "active_confirmed",
    "en_comments": "Long Term Back Order",
    "fr_comments": "Commande en souffrance à long terme",
    "en_drug_brand_name": "NAT-RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "NAT-RIZATRIPTAN",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "Rizatriptan (Benzoate de rizatriptan)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 UD BLS",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254195,
    "drug": {
      "current_status": "MARKETED",
      "id": 65854,
      "drug_code": 98180,
      "updated_date": "2025-05-15T02:38:29-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264386,
          "ingredient": {
            "id": 3102,
            "ingredient_code": 13090,
            "en_name": "GEFITINIB",
            "fr_name": "Géfitinib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02491796",
      "brand_name": "NAT-GEFITINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149783001"
    },
    "created_date": "2025-04-04T18:30:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02491796",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "L01EB",
    "estimated_end_date": "2026-12-31T00:00:00-05:00",
    "actual_start_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-07-03T17:11:44-04:00",
    "status": "active_confirmed",
    "en_comments": "Long Term Back Order",
    "fr_comments": "Commande en souffrance à long terme",
    "en_drug_brand_name": "NAT-GEFITINIB",
    "en_drug_common_name": "GEFITINIB",
    "fr_drug_brand_name": "NAT-GEFITINIB",
    "fr_drug_common_name": "GEFITINIB",
    "en_ingredients": "GEFITINIB",
    "fr_ingredients": "Géfitinib",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 UD BLS",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254205,
    "drug": {
      "current_status": "MARKETED",
      "id": 30412,
      "drug_code": 92460,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261112,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440229",
      "brand_name": "NAT-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2025-04-04T18:34:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440229",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2025-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-03T17:15:12-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "NAT-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "NAT-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254234,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27964,
      "drug_code": 90163,
      "updated_date": "2025-12-03T01:31:56-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8354039,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02416999",
      "brand_name": "RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521001"
    },
    "created_date": "2025-04-04T19:07:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02416999",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-05T05:00:23-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254237,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27966,
      "drug_code": 90164,
      "updated_date": "2025-12-03T01:31:56-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8354040,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02417006",
      "brand_name": "RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521002"
    },
    "created_date": "2025-04-04T19:08:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417006",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-05T05:00:23-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254240,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27968,
      "drug_code": 90165,
      "updated_date": "2025-12-03T01:31:56-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8354041,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02417014",
      "brand_name": "RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521003"
    },
    "created_date": "2025-04-04T19:10:01-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417014",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2025-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-05T05:00:24-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254243,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27970,
      "drug_code": 90166,
      "updated_date": "2025-12-03T01:31:56-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8354042,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02417022",
      "brand_name": "RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521004"
    },
    "created_date": "2025-04-04T19:11:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417022",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2025-06-18T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-06-23T14:24:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine (Tartrate hydrogénée de rivastigmine)",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254329,
    "drug": {
      "current_status": "MARKETED",
      "id": 101385,
      "drug_code": 97660,
      "updated_date": "2021-02-08T05:02:43-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8263946,
          "ingredient": {
            "id": 3736,
            "ingredient_code": 20883,
            "en_name": "ABIRATERONE ACETATE",
            "fr_name": "Acétate d'abiratérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02486393",
      "brand_name": "SANDOZ ABIRATERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152948001"
    },
    "created_date": "2025-04-07T13:07:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02486393",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L02BX",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-13T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ABIRATERONE",
    "en_drug_common_name": "ABIRATERONE",
    "fr_drug_brand_name": "SANDOZ ABIRATERONE",
    "fr_drug_common_name": "ABIRATERONE",
    "en_ingredients": "ABIRATERONE ACETATE",
    "fr_ingredients": "Acétate d'abiratérone",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254332,
    "drug": {
      "current_status": "MARKETED",
      "id": 24610,
      "drug_code": 87201,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258889,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386429",
      "brand_name": "SANDOZ ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434002"
    },
    "created_date": "2025-04-07T13:08:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386429",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-07-25T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-29T05:00:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "SANDOZ ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine (Chlorhydrate d'atomoxétine)",
    "drug_strength": "18MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30HGC",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254335,
    "drug": {
      "current_status": "MARKETED",
      "id": 99916,
      "drug_code": 97996,
      "updated_date": "2020-04-03T06:54:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264215,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489899",
      "brand_name": "SANDOZ DEFERASIROX (TYPE J)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733004"
    },
    "created_date": "2025-04-07T13:09:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489899",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2025-04-18T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-04-22T12:45:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DEFERASIROX (TYPE J)",
    "en_drug_common_name": "DEFERASIROX (TYPE J)",
    "fr_drug_brand_name": "SANDOZ DEFERASIROX (TYPE J)",
    "fr_drug_common_name": "DEFERASIROX (TYPE J)",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "90MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254338,
    "drug": {
      "current_status": "MARKETED",
      "id": 19928,
      "drug_code": 81243,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256966,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327112",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302015"
    },
    "created_date": "2025-04-07T13:10:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327112",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2025-04-11T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-04-15T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "FENTANYL PATCH",
    "fr_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "fr_drug_common_name": "FENTANYL PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl (Citrate de fentanyl)",
    "drug_strength": "12MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5TTSS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254341,
    "drug": {
      "current_status": "MARKETED",
      "id": 20058,
      "drug_code": 81400,
      "updated_date": "2025-05-15T02:32:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257059,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328488",
      "brand_name": "SANDOZ IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2025-04-07T13:12:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328488",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2025-04-18T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-23T19:47:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254344,
    "drug": {
      "current_status": "MARKETED",
      "id": 12436,
      "drug_code": 71020,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254578,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246820",
      "brand_name": "SANDOZ METFORMIN FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2025-04-07T13:13:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246820",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2025-04-25T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-29T05:00:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ METFORMIN FC",
    "en_drug_common_name": "METFORMIN FC",
    "fr_drug_brand_name": "SANDOZ METFORMIN FC",
    "fr_drug_common_name": "METFORMIN FC",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254347,
    "drug": {
      "current_status": "MARKETED",
      "id": 11666,
      "drug_code": 68782,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254338,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244792",
      "brand_name": "SANDOZ MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545010"
    },
    "created_date": "2025-04-07T13:14:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244792",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2025-05-09T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-13T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR",
    "fr_drug_brand_name": "SANDOZ MORPHINE SR",
    "fr_drug_common_name": "MORPHINE SR",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254354,
    "drug": {
      "current_status": "MARKETED",
      "id": 20226,
      "drug_code": 81664,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257167,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330881",
      "brand_name": "AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2025-04-07T13:21:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330881",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-22T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254359,
    "drug": {
      "current_status": "MARKETED",
      "id": 20226,
      "drug_code": 81664,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257167,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330881",
      "brand_name": "AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2025-04-07T13:22:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330881",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-22T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254364,
    "drug": {
      "current_status": "MARKETED",
      "id": 56264,
      "drug_code": 91140,
      "updated_date": "2025-12-03T00:32:37-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260562,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426854",
      "brand_name": "DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2025-04-07T13:30:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426854",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2025-07-18T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-19T13:48:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254367,
    "drug": {
      "current_status": "MARKETED",
      "id": 20894,
      "drug_code": 82851,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257393,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02343029",
      "brand_name": "LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134001"
    },
    "created_date": "2025-04-07T13:31:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02343029",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2025-05-02T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-02T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254370,
    "drug": {
      "current_status": "MARKETED",
      "id": 20896,
      "drug_code": 82852,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257394,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02343037",
      "brand_name": "LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134006"
    },
    "created_date": "2025-04-07T13:32:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02343037",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254373,
    "drug": {
      "current_status": "MARKETED",
      "id": 103490,
      "drug_code": 102170,
      "updated_date": "2022-12-08T06:17:33-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8267620,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02532689",
      "brand_name": "MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2025-04-07T13:33:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02532689",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T05:00:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254376,
    "drug": {
      "current_status": "MARKETED",
      "id": 21428,
      "drug_code": 83820,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257658,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02352974",
      "brand_name": "OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2025-04-07T13:35:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352974",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T05:00:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254379,
    "drug": {
      "current_status": "MARKETED",
      "id": 98919,
      "drug_code": 94403,
      "updated_date": "2020-04-03T06:53:11-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262077,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457032",
      "brand_name": "TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2025-04-07T13:36:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457032",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2025-05-02T00:00:00-04:00",
    "estimated_end_date": "2025-09-26T00:00:00-04:00",
    "actual_start_date": "2025-05-01T00:00:00-04:00",
    "actual_end_date": "2025-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-26T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254384,
    "drug": {
      "current_status": "MARKETED",
      "id": 54596,
      "drug_code": 95610,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262699,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467747",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434001"
    },
    "created_date": "2025-04-07T13:43:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467747",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-06-06T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-05T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "fr_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine (Chlorhydrate d'atomoxétine)",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254387,
    "drug": {
      "current_status": "MARKETED",
      "id": 54598,
      "drug_code": 95611,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262700,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467755",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434002"
    },
    "created_date": "2025-04-07T13:45:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467755",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-06-06T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-05T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "fr_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine (Chlorhydrate d'atomoxétine)",
    "drug_strength": "18MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254390,
    "drug": {
      "current_status": "MARKETED",
      "id": 54600,
      "drug_code": 95612,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262701,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467763",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434003"
    },
    "created_date": "2025-04-07T13:48:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467763",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-08-15T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine (Chlorhydrate d'atomoxétine)",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254393,
    "drug": {
      "current_status": "MARKETED",
      "id": 54602,
      "drug_code": 95613,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262702,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467771",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2025-04-07T13:49:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467771",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-09-12T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-20T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine (Chlorhydrate d'atomoxétine)",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254396,
    "drug": {
      "current_status": "MARKETED",
      "id": 54604,
      "drug_code": 95614,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262703,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467798",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2025-04-07T13:50:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467798",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-06-06T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-05T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "fr_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine (Chlorhydrate d'atomoxétine)",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254399,
    "drug": {
      "current_status": "MARKETED",
      "id": 54606,
      "drug_code": 95615,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262704,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467801",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434006"
    },
    "created_date": "2025-04-07T13:51:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467801",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-09-19T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-09-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-18T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine (Chlorhydrate d'atomoxétine)",
    "drug_strength": "80MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254402,
    "drug": {
      "current_status": "MARKETED",
      "id": 21484,
      "drug_code": 83857,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257674,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353377",
      "brand_name": "METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2025-04-07T13:53:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353377",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-26T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "fr_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "en_drug_brand_name": "METFORMIN",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "METFORMIN",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "360",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254405,
    "drug": {
      "current_status": "MARKETED",
      "id": 21484,
      "drug_code": 83857,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257674,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353377",
      "brand_name": "METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2025-04-07T13:55:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353377",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2025-07-04T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-04T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "fr_comments": "ITEM ON ALLOCATION / ARTICLE D'ATTRIBUTION",
    "en_drug_brand_name": "METFORMIN",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "METFORMIN",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254439,
    "drug": {
      "current_status": "MARKETED",
      "id": 22154,
      "drug_code": 84531,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257933,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360349",
      "brand_name": "ZYTRAM XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694005"
    },
    "created_date": "2025-04-07T19:11:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360349",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2025-04-07T00:00:00-04:00",
    "estimated_end_date": "2025-07-04T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-06-20T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZYTRAM XL",
    "en_drug_common_name": "Tramadol Hydrochloride",
    "fr_drug_brand_name": "Zytram",
    "fr_drug_common_name": "Chlorhydrate de tramadol",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254442,
    "drug": {
      "current_status": "MARKETED",
      "id": 100259,
      "drug_code": 98620,
      "updated_date": "2025-05-15T02:39:13-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264823,
          "ingredient": {
            "id": 1568,
            "ingredient_code": 11180,
            "en_name": "CEFAZOLIN",
            "fr_name": "Céfazoline (Céfazoline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02496313",
      "brand_name": "CEFAZOLIN IN DEXTROSE INJECTION, USP",
      "brand_name_fr": "CÉFAZOLINE DANS DU DEXTROSE INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE BAGS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109442009"
    },
    "created_date": "2025-04-07T19:41:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496313",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2025-06-14T00:00:00-04:00",
    "actual_start_date": "2025-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2025-11-19T18:22:23-05:00",
    "status": "active_confirmed",
    "en_comments": "The root cause is a shortage of active pharmaceutical ingredients (API). Foreign authorized supply is available.",
    "en_drug_brand_name": "CEFAZOLIN INJECTION, USP",
    "en_drug_common_name": "Cefazolin Injection USP 1000 mg / 50 mL",
    "fr_drug_brand_name": "CEFAZOLIN INJECTION, USP",
    "fr_drug_common_name": "Cefazolin Injection USP 1000 mg / 50 mL",
    "en_ingredients": "CEFAZOLIN",
    "fr_ingredients": "Céfazoline (Céfazoline sodique)",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "CA2G3503– 24 bags/case",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 254446,
    "drug": {
      "current_status": "MARKETED",
      "id": 100259,
      "drug_code": 98620,
      "updated_date": "2025-05-15T02:39:13-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264823,
          "ingredient": {
            "id": 1568,
            "ingredient_code": 11180,
            "en_name": "CEFAZOLIN",
            "fr_name": "Céfazoline (Céfazoline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02496313",
      "brand_name": "CEFAZOLIN IN DEXTROSE INJECTION, USP",
      "brand_name_fr": "CÉFAZOLINE DANS DU DEXTROSE INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE BAGS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109442009"
    },
    "created_date": "2025-04-07T19:47:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496313",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2025-06-02T00:00:00-04:00",
    "actual_start_date": "2025-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2025-11-19T18:22:53-05:00",
    "status": "active_confirmed",
    "en_comments": "The root cause is a shortage of active pharmaceutical ingredients (API). Foreign authorized supply is available.",
    "en_drug_brand_name": "CEFAZOLIN INJECTION, USP",
    "en_drug_common_name": "Cefazolin Injection USP 2000 mg / 100 mL",
    "fr_drug_brand_name": "CEFAZOLIN INJECTION, USP",
    "fr_drug_common_name": "Cefazolin Injection USP 2000 mg / 100 mL",
    "en_ingredients": "CEFAZOLIN",
    "fr_ingredients": "Céfazoline (Céfazoline sodique)",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "CA2G3508 – 12 bags/case",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 254491,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13098,
      "drug_code": 72486,
      "updated_date": "2025-12-03T01:22:18-05:00",
      "company": {
        "id": 190,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 5181,
        "mfr_code": "SRO08",
        "name": "EMD SERONO, A DIVISION OF EMD INC., CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2695 NORTH SHERIDAN WAY, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5K 2N6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338830,
          "ingredient": {
            "id": 3076,
            "ingredient_code": 11457,
            "en_name": "FOLLITROPIN ALFA",
            "fr_name": "Follitropine alfa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02248154",
      "brand_name": "GONAL-F",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145621003"
    },
    "created_date": "2025-04-08T12:25:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248154",
    "company_name": "EMD SERONO, A DIVISION OF EMD INC., CANADA",
    "atc_number": "G03GA",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "discontinuation_date": "2025-08-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Alternate formats available: Gonal-f Pens",
    "fr_discontinuation_comments": "Autres formats disponible: Gonal-f Pen",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-09-03T17:39:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "GONAL-F",
    "en_drug_common_name": "Follitropin alfa for Injection",
    "fr_drug_brand_name": "Gonal-f",
    "fr_drug_common_name": "Follitropine alfa pour injection",
    "en_ingredients": "FOLLITROPIN ALFA",
    "fr_ingredients": "Follitropine alfa",
    "drug_strength": "5.5MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "Single unit - 3mL vial",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254610,
    "drug": {
      "current_status": "MARKETED",
      "id": 101991,
      "drug_code": 100647,
      "updated_date": "2021-07-08T05:10:10-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8266371,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02517132",
      "brand_name": "DEXTROSE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102181001"
    },
    "created_date": "2025-04-08T20:28:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02517132",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "estimated_end_date": "2026-01-09T00:00:00-05:00",
    "actual_start_date": "2025-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-12-17T19:07:38-05:00",
    "status": "active_confirmed",
    "en_comments": "We have released a batch, but the product is still subject to allocation.",
    "fr_comments": "Un lot a été libéré, toutefois le produit reste assujetti à une allocation.",
    "en_drug_brand_name": "DEXTROSE INJECTION",
    "en_drug_common_name": "DEXTROSE INJECTION USP",
    "fr_drug_brand_name": "INJECTION DE DEXTROSE USP",
    "fr_drug_common_name": "INJECTION DE DEXTROSE",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "50%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 50mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254613,
    "drug": {
      "current_status": "MARKETED",
      "id": 101599,
      "drug_code": 100171,
      "updated_date": "2021-03-08T05:59:40-05:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8266093,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02512424",
      "brand_name": "BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896002"
    },
    "created_date": "2025-04-08T20:34:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02512424",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2025-04-30T00:00:00-04:00",
    "estimated_end_date": "2025-09-12T00:00:00-04:00",
    "actual_start_date": "2025-05-02T00:00:00-04:00",
    "actual_end_date": "2025-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-09-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP",
    "en_drug_common_name": "BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION",
    "fr_drug_brand_name": "CHLORHYDRATE DE BUPIVACAINE DANS DU DEXTROSE INJECTABLE USP",
    "fr_drug_common_name": "CHLORHYDRATE DE BUPIVACAINE DANS DU DEXTROSE INJECTABLE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRASPINAL",
    "drug_route_fr": "Intrarachidienne",
    "drug_package_quantity": "10 x 2mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254635,
    "drug": {
      "current_status": "MARKETED",
      "id": 3768,
      "drug_code": 19257,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252468,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02156091",
      "brand_name": "NORITATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81548",
      "number_of_ais": "1",
      "ai_group_no": "0102572009"
    },
    "created_date": "2025-04-09T14:15:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02156091",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D06BX",
    "atc_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
    "anticipated_start_date": "2025-05-28T00:00:00-04:00",
    "estimated_end_date": "2025-06-06T00:00:00-04:00",
    "actual_end_date": "2025-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-14T15:42:34-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "NORITATE",
    "en_drug_common_name": "NORITATE",
    "fr_drug_brand_name": "NORITATE",
    "fr_drug_common_name": "NORITATE",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "45g",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254642,
    "drug": {
      "current_status": "MARKETED",
      "id": 100427,
      "drug_code": 98785,
      "updated_date": "2020-06-16T22:21:13-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264996,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02498057",
      "brand_name": "UCERIS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116807014"
    },
    "created_date": "2025-04-09T14:20:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02498057",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "A07EA",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2025-05-15T00:00:00-04:00",
    "estimated_end_date": "2025-08-15T00:00:00-04:00",
    "actual_start_date": "2025-05-20T00:00:00-04:00",
    "actual_end_date": "2025-08-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-06T19:25:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "UCERIS",
    "en_drug_common_name": "UCERIS",
    "fr_drug_brand_name": "UCERIS",
    "fr_drug_common_name": "UCERIS",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "2MG",
    "drug_dosage_form": "FOAM",
    "drug_dosage_form_fr": "MOUSSE",
    "drug_route": "RECTAL",
    "drug_route_fr": "Rectale",
    "drug_package_quantity": "2 foam cans",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254647,
    "drug": {
      "current_status": "MARKETED",
      "id": 17552,
      "drug_code": 78575,
      "updated_date": "2025-05-15T02:32:01-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256179,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02300451",
      "brand_name": "GLUMETZA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773003"
    },
    "created_date": "2025-04-09T14:27:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02300451",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2025-05-15T00:00:00-04:00",
    "estimated_end_date": "2025-05-30T00:00:00-04:00",
    "actual_end_date": "2025-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-05-14T15:45:27-04:00",
    "status": "avoided_shortage",
    "en_comments": "other",
    "fr_comments": "other",
    "en_drug_brand_name": "GLUMETZA",
    "en_drug_common_name": "GLUMETZA",
    "fr_drug_brand_name": "GLUMETZA",
    "fr_drug_common_name": "GLUMETZA",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254656,
    "drug": {
      "current_status": "MARKETED",
      "id": 6140,
      "drug_code": 42848,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252986,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184451",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9015",
      "number_of_ais": "1",
      "ai_group_no": "0104545012"
    },
    "created_date": "2025-04-09T15:05:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184451",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2025-04-09T00:00:00-04:00",
    "estimated_end_date": "2025-04-24T00:00:00-04:00",
    "actual_start_date": "2025-04-08T00:00:00-04:00",
    "actual_end_date": "2025-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-28T17:15:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "MORPHINE SULFATE",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254659,
    "drug": {
      "current_status": "MARKETED",
      "id": 25352,
      "drug_code": 87822,
      "updated_date": "2025-12-03T00:32:06-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259191,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392968",
      "brand_name": "MYLAN-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2025-04-09T15:07:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392968",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2025-04-09T00:00:00-04:00",
    "estimated_end_date": "2025-04-11T00:00:00-04:00",
    "actual_start_date": "2025-04-09T00:00:00-04:00",
    "actual_end_date": "2025-04-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-04-14T17:57:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "MYLAN-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine (Atorvastatine calcique)",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254670,
    "drug": {
      "current_status": "MARKETED",
      "id": 30594,
      "drug_code": 92648,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261229,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442124",
      "brand_name": "METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2025-04-09T15:18:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442124",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2025-04-07T00:00:00-04:00",
    "estimated_end_date": "2025-05-05T00:00:00-04:00",
    "actual_end_date": "2025-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-06T17:18:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METOPROLOL-L",
    "en_drug_common_name": "METOPROLOL-L",
    "fr_drug_brand_name": "METOPROLOL-L",
    "fr_drug_common_name": "METOPROLOL-L",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254687,
    "drug": {
      "current_status": "MARKETED",
      "id": 24466,
      "drug_code": 87093,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258832,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385295",
      "brand_name": "IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2025-04-09T15:39:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385295",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2025-04-28T00:00:00-04:00",
    "estimated_end_date": "2025-05-05T00:00:00-04:00",
    "actual_end_date": "2025-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254690,
    "drug": {
      "current_status": "MARKETED",
      "id": 30626,
      "drug_code": 92678,
      "updated_date": "2025-12-03T00:32:51-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261246,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442434",
      "brand_name": "AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2025-04-09T15:41:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442434",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2025-04-17T00:00:00-04:00",
    "estimated_end_date": "2025-05-12T00:00:00-04:00",
    "actual_end_date": "2025-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-22T18:46:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254697,
    "drug": {
      "current_status": "MARKETED",
      "id": 31284,
      "drug_code": 93497,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261599,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449153",
      "brand_name": "AURO-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555003"
    },
    "created_date": "2025-04-09T18:04:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449153",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2025-05-15T00:00:00-04:00",
    "actual_start_date": "2025-04-09T00:00:00-04:00",
    "actual_end_date": "2025-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T15:47:48-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "AURO-BETAHISTINE",
    "en_drug_common_name": "Auro-Betahistine 16mg Tab 100 Btl",
    "fr_drug_brand_name": "AURO-BETAHISTINE",
    "fr_drug_common_name": "Auro-Betahistine 16mg Tab 100 Btl",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bétahistine",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254712,
    "drug": {
      "current_status": "MARKETED",
      "id": 11216,
      "drug_code": 67590,
      "updated_date": "2025-05-15T02:31:15-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8254210,
          "ingredient": {
            "id": 764,
            "ingredient_code": 8603,
            "en_name": "STREPTOMYCIN",
            "fr_name": "Streptomycine (Sulfate de streptomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02243660",
      "brand_name": "STREPTOMYCIN FOR INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131356002"
    },
    "created_date": "2025-04-10T14:30:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02243660",
    "company_name": "STERIMAX INC",
    "atc_number": "J01GA",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "anticipated_discontinuation_date": "2026-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Limited inventory remains at McKesson.  The expiry date on the remaining stock is April 30, 2026.",
    "fr_supply_disruption_mitigation": "Inventaire en quantité limitée est disponible chez McKesson.  La date d'expiration est le 30 avril 2026.",
    "en_discontinuation_comments": "Inventory has been depleted at SteriMax.  Limited inventory remains at McKesson.  Product will be discontinued upon depletion of the remaining inventory.",
    "fr_discontinuation_comments": "Inventaire a été épuisé chez SteriMax. Inventaire en quantité limitée est disponible chez McKesson.  Le produit sera discontinué dès que l'inventaire restant sera épuisé.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-10T14:33:19-04:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "STREPTOMYCIN FOR INJECTION USP",
    "en_drug_common_name": "STREPTOMYCIN FOR INJECTION USP",
    "fr_drug_brand_name": "STREPTOMYCINE POUR INJECTION USP",
    "fr_drug_common_name": "STREPTOMYCINE POUR INJECTION USP",
    "en_ingredients": "STREPTOMYCIN",
    "fr_ingredients": "Streptomycine (Sulfate de streptomycine)",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 VIAL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254786,
    "drug": {
      "current_status": "MARKETED",
      "id": 12734,
      "drug_code": 71589,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254655,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247346",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "800MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929005"
    },
    "created_date": "2025-04-10T15:21:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247346",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02BF",
    "estimated_end_date": "2025-06-04T00:00:00-04:00",
    "actual_start_date": "2025-04-10T00:00:00-04:00",
    "actual_end_date": "2025-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-16T14:21:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 800MG TAB",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 800MG TAB",
    "fr_drug_common_name": "GABAPENTIN 800MG TAB",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254789,
    "drug": {
      "current_status": "MARKETED",
      "id": 15566,
      "drug_code": 76239,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255580,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276712",
      "brand_name": "TEVA-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2025-04-10T15:23:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02276712",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-05-10T00:00:00-04:00",
    "actual_start_date": "2025-04-10T00:00:00-04:00",
    "actual_end_date": "2025-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-08T18:54:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE 2.5MG TAB",
    "fr_drug_brand_name": "TEVA-OLANZAPINE 2.5MG TAB",
    "fr_drug_common_name": "OLANZAPINE 2.5MG TAB",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254792,
    "drug": {
      "current_status": "MARKETED",
      "id": 16870,
      "drug_code": 77858,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255957,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293218",
      "brand_name": "TEVA-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2025-04-10T15:25:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293218",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-10-20T00:00:00-04:00",
    "actual_start_date": "2025-04-10T00:00:00-04:00",
    "actual_end_date": "2025-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-24T18:58:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM 20MG TAB",
    "fr_drug_brand_name": "TEVA-CITALOPRAM 20MG TAB",
    "fr_drug_common_name": "CITALOPRAM 20MG TAB",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram (Bromhydrate de citalopram)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254830,
    "drug": {
      "current_status": "MARKETED",
      "id": 1920,
      "drug_code": 14077,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251910,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251909,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251908,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251907,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251906,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "520",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251905,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251904,
          "ingredient": {
            "id": 646,
            "ingredient_code": 8700,
            "en_name": "L-LYSINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de L-lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251903,
          "ingredient": {
            "id": 1014,
            "ingredient_code": 750,
            "en_name": "L-PHENYLALANINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251902,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251901,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.04",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251900,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251899,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251898,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "230",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251897,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "220",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251896,
          "ingredient": {
            "id": 1016,
            "ingredient_code": 751,
            "en_name": "L-LEUCINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02013886",
      "brand_name": "CLINIMIX",
      "brand_name_fr": "",
      "descriptor": "5% AMINO ACIDS (BLEND B) WITHOUT ELECTROLYTES IN 5% DEXTROSE INJECTION",
      "pediatric_flag": false,
      "accession_number": "75584",
      "number_of_ais": "15",
      "ai_group_no": "1550853015"
    },
    "created_date": "2025-04-10T19:31:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02013886",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "discontinuation_date": "2025-08-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-08-19T17:19:53-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLINIMIX",
    "en_drug_common_name": "5% Amino Acids (Blend B) without Electrolytes in 5% Dextrose Injection",
    "fr_drug_brand_name": "CLINIMIX",
    "fr_drug_common_name": "5% Amino Acids (Blend B) without Electrolytes in 5% Dextrose Injection",
    "en_ingredients": "L-ARGININE\r\nGLYCINE\r\nL-ALANINE\r\nMETHIONINE\r\nL-LYSINE HYDROCHLORIDE\r\nL-PHENYLALANINE HYDROCHLORIDE\r\nL-LEUCINE HYDROCHLORIDE\r\nDEXTROSE\r\nL-ISOLEUCINE\r\nL-TYROSINE\r\nL-PROLINE\r\nTRYPTOPHAN\r\nL-THREONINE\r\nHISTIDINE\r\nL-VALINE",
    "fr_ingredients": "L-arginine\r\nGlycine\r\nL-ALANINE\r\nMéhionine\r\nChlorhydrate de L-lysine\r\nChlorhydrate de l-phénylalanine\r\nChlorhydrate de l-leucine\r\nDextrose\r\nL-isoleucine\r\nL-tyrosine\r\nL-proline\r\nTryptophane\r\nL-thréonine\r\nHistidine\r\nL-valine",
    "drug_strength": "520MG\r\n1.04G\r\n1.04G\r\n290MG\r\n290MG\r\n310MG\r\n310MG\r\n5G\r\n240MG\r\n20MG\r\n210MG\r\n90MG\r\n210MG\r\n220MG\r\n230MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254838,
    "drug": {
      "current_status": "MARKETED",
      "id": 51287,
      "drug_code": 94919,
      "updated_date": "2025-05-15T02:35:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262353,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461552",
      "brand_name": "APO-DEFERASIROX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733002"
    },
    "created_date": "2025-04-10T19:37:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461552",
    "company_name": "APOTEX INC",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-08T00:00:00-04:00",
    "actual_end_date": "2025-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T19:01:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DEFERASIROX",
    "en_drug_common_name": "DEFERASIROX",
    "fr_drug_brand_name": "APO-DEFERASIROX",
    "fr_drug_common_name": "DEFERASIROX",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET FOR SUSPENSION",
    "drug_dosage_form_fr": "Comprimé pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254841,
    "drug": {
      "current_status": "MARKETED",
      "id": 61724,
      "drug_code": 94301,
      "updated_date": "2025-05-15T02:35:29-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261993,
          "ingredient": {
            "id": 3194,
            "ingredient_code": 13053,
            "en_name": "BORTEZOMIB",
            "fr_name": "Bortézomib (Bortézomib, ester boronique de mannitol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02456176",
      "brand_name": "BORTEZOMIB",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150433001"
    },
    "created_date": "2025-04-10T19:39:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456176",
    "company_name": "APOTEX INC",
    "atc_number": "L01XG",
    "estimated_end_date": "2025-04-25T00:00:00-04:00",
    "actual_start_date": "2025-04-08T00:00:00-04:00",
    "actual_end_date": "2025-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-17T14:03:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BORTEZOMIB",
    "en_drug_common_name": "BORTEZOMIB",
    "fr_drug_brand_name": "BORTEZOMIB",
    "fr_drug_common_name": "BORTEZOMIB",
    "en_ingredients": "BORTEZOMIB",
    "fr_ingredients": "Bortézomib (Bortézomib, ester boronique de mannitol)",
    "drug_strength": "3.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254844,
    "drug": {
      "current_status": "MARKETED",
      "id": 23432,
      "drug_code": 8602,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251107,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00751170",
      "brand_name": "APO-METOPROLOL (TYPE L)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67172",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2025-04-10T19:40:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00751170",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2025-07-11T00:00:00-04:00",
    "actual_start_date": "2025-04-08T00:00:00-04:00",
    "actual_end_date": "2025-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-04T20:05:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METOPROLOL (TYPE L)",
    "en_drug_common_name": "METOPROLOL (TYPE L)",
    "fr_drug_brand_name": "APO-METOPROLOL (TYPE L)",
    "fr_drug_common_name": "METOPROLOL (TYPE L)",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254847,
    "drug": {
      "current_status": "MARKETED",
      "id": 22180,
      "drug_code": 84558,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257940,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360616",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2025-04-10T19:41:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360616",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-04-25T00:00:00-04:00",
    "actual_start_date": "2025-04-08T00:00:00-04:00",
    "actual_end_date": "2025-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-25T19:12:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "APO-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254858,
    "drug": {
      "current_status": "MARKETED",
      "id": 61186,
      "drug_code": 95755,
      "updated_date": "2025-12-03T00:33:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262794,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "110",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468905",
      "brand_name": "APO-DABIGATRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467002"
    },
    "created_date": "2025-04-10T20:37:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468905",
    "company_name": "APOTEX INC",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-08T00:00:00-04:00",
    "actual_end_date": "2025-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-23T19:10:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DABIGATRAN",
    "en_drug_common_name": "DABIGATRAN",
    "fr_drug_brand_name": "APO-DABIGATRAN",
    "fr_drug_common_name": "DABIGATRAN",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "Dabigatran étexilate (Mésilate de dabigatran étexilate)",
    "drug_strength": "110MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254873,
    "drug": {
      "current_status": "MARKETED",
      "id": 52181,
      "drug_code": 92868,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261353,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261352,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443902",
      "brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
      "brand_name_fr": "MYLAN-EMTRICITABINE/TÉNOFOVIR DISOPROXIL",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251568001"
    },
    "created_date": "2025-04-11T13:43:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443902",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2025-05-14T00:00:00-04:00",
    "actual_start_date": "2025-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-21T12:18:38-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "en_drug_common_name": "EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "fr_drug_brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "fr_drug_common_name": "EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "en_ingredients": "EMTRICITABINE\r\nTENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Emtricitabine\r\nFumarate de ténofovir disoproxil",
    "drug_strength": "200MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254876,
    "drug": {
      "current_status": "MARKETED",
      "id": 101321,
      "drug_code": 99838,
      "updated_date": "2021-01-09T23:58:16-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8265867,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02509067",
      "brand_name": "ACH-METHOTREXATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107545001"
    },
    "created_date": "2025-04-11T13:48:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02509067",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2026-01-30T00:00:00-05:00",
    "actual_start_date": "2025-04-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-11-07T14:55:33-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-METHOTREXATE",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "ACH Méthotrexate",
    "fr_drug_common_name": "Méthotrexate",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate (Méthotrexate sodique)",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254897,
    "drug": {
      "current_status": "MARKETED",
      "id": 12756,
      "drug_code": 71632,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254660,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247387",
      "brand_name": "PMS-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101048001"
    },
    "created_date": "2025-04-11T15:38:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247387",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C03AA",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2025-05-01T00:00:00-04:00",
    "actual_start_date": "2025-04-10T00:00:00-04:00",
    "actual_end_date": "2025-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-29T21:04:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-HYDROCHLOROTHIAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "pms - HYDROCHLOROTHIAZIDE",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254932,
    "drug": {
      "current_status": "MARKETED",
      "id": 22276,
      "drug_code": 84680,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8257970,
          "ingredient": {
            "id": 2544,
            "ingredient_code": 12633,
            "en_name": "FORMOTEROL FUMARATE DIHYDRATE",
            "fr_name": "Fumarate de formotérol dihydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8257969,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02361752",
      "brand_name": "ZENHALE",
      "brand_name_fr": "ZENHALE",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252871005"
    },
    "created_date": "2025-04-11T19:21:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361752",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2025-04-18T00:00:00-04:00",
    "actual_start_date": "2025-04-10T00:00:00-04:00",
    "actual_end_date": "2025-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-04-16T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZENHALE",
    "en_drug_common_name": "mometasone furoate & formoterol fumarate dihydrate inhalation aerosol",
    "fr_drug_brand_name": "ZENHALE",
    "fr_drug_common_name": "furoate de mométasone et fumarate de formotérol dihydraté en aérosol pour inhalation",
    "en_ingredients": "FORMOTEROL FUMARATE DIHYDRATE\r\nMOMETASONE FUROATE",
    "fr_ingredients": "Fumarate de formotérol dihydraté\r\nFuroate de mométasone",
    "drug_strength": "5MCG\r\n100MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "120 dose",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254935,
    "drug": {
      "current_status": "MARKETED",
      "id": 4294,
      "drug_code": 20256,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252691,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1440",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02187078",
      "brand_name": "HAVRIX 1440",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "82560",
      "number_of_ais": "1",
      "ai_group_no": "0165325001"
    },
    "created_date": "2025-04-11T19:47:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187078",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2025-05-30T00:00:00-04:00",
    "actual_start_date": "2025-04-09T00:00:00-04:00",
    "actual_end_date": "2025-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-30T01:33:19-04:00",
    "status": "resolved",
    "en_comments": "Doses reserved for Public programs, supply disruptions may be seen in the private market.",
    "fr_comments": "Doses réservées pour les programmes publics, des ruptures d’approvisionnement pourraient toucher le marché privé.",
    "en_drug_brand_name": "HAVRIX 1440",
    "en_drug_common_name": "hepatitis A vaccine, inactivated",
    "fr_drug_brand_name": "HAVRIX 1440",
    "fr_drug_common_name": "vaccin contre l’hépatite A, inactivé",
    "en_ingredients": "HEPATITIS A VIRUS, INACTIVATED",
    "fr_ingredients": "Virus inactivé contre l'hépatite a, inactivé",
    "drug_strength": "1440UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1's (prefilled syringe / seringue préremplie)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254942,
    "drug": {
      "current_status": "MARKETED",
      "id": 23788,
      "drug_code": 86440,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8258573,
          "ingredient": {
            "id": 3482,
            "ingredient_code": 20387,
            "en_name": "RIVAROXABAN",
            "fr_name": "Rivaroxaban"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378612",
      "brand_name": "XARELTO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152487003"
    },
    "created_date": "2025-04-11T20:36:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378612",
    "company_name": "BAYER INC",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2025-04-30T00:00:00-04:00",
    "estimated_end_date": "2025-05-15T00:00:00-04:00",
    "actual_start_date": "2025-04-29T00:00:00-04:00",
    "actual_end_date": "2025-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T00:18:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XARELTO",
    "en_drug_common_name": "RIVAROXABAN",
    "fr_drug_brand_name": "XARELTO",
    "fr_drug_common_name": "Rivaroxaban",
    "en_ingredients": "RIVAROXABAN",
    "fr_ingredients": "Rivaroxaban",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254985,
    "drug": {
      "current_status": "MARKETED",
      "id": 103211,
      "drug_code": 97931,
      "updated_date": "2022-10-08T04:04:56-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264171,
          "ingredient": {
            "id": 3764,
            "ingredient_code": 21078,
            "en_name": "APIXABAN",
            "fr_name": "Apixaban"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489236",
      "brand_name": "SANDOZ APIXABAN SDZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153051002"
    },
    "created_date": "2025-04-14T13:27:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489236",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-14T00:00:00-04:00",
    "actual_end_date": "2025-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-06T05:00:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ APIXABAN SDZ",
    "en_drug_common_name": "APIXABAN SDZ",
    "fr_drug_brand_name": "SANDOZ APIXABAN SDZ",
    "fr_drug_common_name": "APIXABAN SDZ",
    "en_ingredients": "APIXABAN",
    "fr_ingredients": "Apixaban",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254988,
    "drug": {
      "current_status": "MARKETED",
      "id": 19680,
      "drug_code": 81037,
      "updated_date": "2025-12-03T00:31:26-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256870,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324954",
      "brand_name": "SANDOZ ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2025-04-14T13:27:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324954",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-14T00:00:00-04:00",
    "actual_end_date": "2025-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-20T12:47:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "SANDOZ ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine (Atorvastatine calcique)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254991,
    "drug": {
      "current_status": "MARKETED",
      "id": 19130,
      "drug_code": 80390,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256705,
          "ingredient": {
            "id": 1336,
            "ingredient_code": 349,
            "en_name": "ROCURONIUM BROMIDE",
            "fr_name": "Bromure de rocuronium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02318415",
      "brand_name": "ROCURONIUM BROMIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126317001"
    },
    "created_date": "2025-04-14T13:28:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318415",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M03AC",
    "atc_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
    "estimated_end_date": "2025-04-18T00:00:00-04:00",
    "actual_start_date": "2025-04-14T00:00:00-04:00",
    "actual_end_date": "2025-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-04-22T12:48:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ROCURONIUM BROMIDE INJECTION",
    "en_drug_common_name": "ROCURONIUM BROMIDE INJECTION",
    "fr_drug_brand_name": "ROCURONIUM BROMIDE INJECTION",
    "fr_drug_common_name": "ROCURONIUM BROMIDE INJECTION",
    "en_ingredients": "ROCURONIUM BROMIDE",
    "fr_ingredients": "Bromure de rocuronium",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254994,
    "drug": {
      "current_status": "MARKETED",
      "id": 30896,
      "drug_code": 93028,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261417,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445077",
      "brand_name": "FINASTERIDE",
      "brand_name_fr": "FINASTERIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2025-04-14T14:11:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445077",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2025-05-02T00:00:00-04:00",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2025-05-01T00:00:00-04:00",
    "actual_end_date": "2025-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 254997,
    "drug": {
      "current_status": "MARKETED",
      "id": 30666,
      "drug_code": 92700,
      "updated_date": "2025-05-15T02:34:52-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261264,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442655",
      "brand_name": "ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2025-04-14T14:13:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442655",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2025-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-03T16:37:09-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "ZOLMITRIPTAN",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255039,
    "drug": {
      "current_status": "MARKETED",
      "id": 6304,
      "drug_code": 43175,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8253034,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216213",
      "brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9488",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2025-04-14T18:50:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216213",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2025-05-28T00:00:00-04:00",
    "actual_start_date": "2025-04-07T00:00:00-04:00",
    "actual_end_date": "2025-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-06-04T11:22:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
    "en_drug_common_name": "CLOBETASOL PROPIONATE",
    "fr_drug_brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
    "fr_drug_common_name": "CLOBETASOL PROPIONATE",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255042,
    "drug": {
      "current_status": "MARKETED",
      "id": 52259,
      "drug_code": 94902,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262341,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262340,
          "ingredient": {
            "id": 2676,
            "ingredient_code": 11857,
            "en_name": "EFAVIRENZ",
            "fr_name": "Éfavirenz"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262339,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461412",
      "brand_name": "MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0352327001"
    },
    "created_date": "2025-04-14T18:54:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461412",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2024-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-14T18:56:20-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
    "en_drug_common_name": "TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE EFAVIRENZ",
    "fr_drug_brand_name": "MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
    "fr_drug_common_name": "TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE EFAVIRENZ",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE\r\nEMTRICITABINE\r\nEFAVIRENZ",
    "fr_ingredients": "Fumarate de ténofovir disoproxil\r\nEmtricitabine\r\nÉfavirenz",
    "drug_strength": "300MG\r\n200MG\r\n600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255076,
    "drug": {
      "current_status": "MARKETED",
      "id": 49642,
      "drug_code": 92813,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261324,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261323,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443449",
      "brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED-RELEASE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252870002"
    },
    "created_date": "2025-04-15T14:31:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443449",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2025-04-23T00:00:00-04:00",
    "actual_start_date": "2025-04-14T00:00:00-04:00",
    "actual_end_date": "2025-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-23T12:16:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "en_drug_common_name": "ESOMEPRAZOLE NAPROXEN",
    "fr_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "fr_drug_common_name": "ESOMEPRAZOLE NAPROXEN",
    "en_ingredients": "ESOMEPRAZOLE\r\nNAPROXEN",
    "fr_ingredients": "Ésoméprazole (Ésoméprazole magnésien dihydraté)\r\nNaproxène",
    "drug_strength": "20MG\r\n500MG",
    "drug_dosage_form": "TABLET (IMMEDIATE AND DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate et retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255081,
    "drug": {
      "current_status": "MARKETED",
      "id": 11616,
      "drug_code": 68628,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254327,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244641",
      "brand_name": "BIAXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752004"
    },
    "created_date": "2025-04-15T14:33:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244641",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2025-08-18T00:00:00-04:00",
    "estimated_end_date": "2025-09-09T00:00:00-04:00",
    "actual_end_date": "2025-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-21T11:51:31-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "BIAXIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "BIAXIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "105ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255084,
    "drug": {
      "current_status": "MARKETED",
      "id": 100816,
      "drug_code": 99219,
      "updated_date": "2020-08-04T23:50:49-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265441,
          "ingredient": {
            "id": 472,
            "ingredient_code": 10114,
            "en_name": "ISOPROTERENOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'isoprotérénol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02502623",
      "brand_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "INJECTION DE CHLORHYDRATE D'ISOPROTÉRÉNOL USP",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101873001"
    },
    "created_date": "2025-04-15T16:42:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502623",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2025-04-15T00:00:00-04:00",
    "estimated_end_date": "2025-05-31T00:00:00-04:00",
    "actual_start_date": "2025-04-15T00:00:00-04:00",
    "actual_end_date": "2025-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-06-19T18:08:29-04:00",
    "status": "resolved",
    "en_comments": "Isoproterenol 0.2mg/1mL pack is available as substitute",
    "fr_comments": "Isoproterenol 0.2mg/1mL pack is available as substitute",
    "en_drug_brand_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "fr_drug_brand_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "en_ingredients": "ISOPROTERENOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'isoprotérénol",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1MG/5ML (PACK 10 VIALS)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255091,
    "drug": {
      "current_status": "MARKETED",
      "id": 11462,
      "drug_code": 68110,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 80,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4489,
        "mfr_code": "LEO08",
        "name": "LEO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6 ADELAIDE STREET EAST, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5C 1H6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254269,
          "ingredient": {
            "id": 2242,
            "ingredient_code": 167,
            "en_name": "TACROLIMUS",
            "fr_name": "Tacrolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02244149",
      "brand_name": "PROTOPIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127857005"
    },
    "created_date": "2025-04-15T19:15:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02244149",
    "company_name": "LEO PHARMA INC",
    "atc_number": "D11AH",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "discontinuation_date": "2025-04-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "N/A",
    "fr_supply_disruption_mitigation": "N/A",
    "en_discontinuation_comments": "The 30g pack size will no longer be available for the market;  Only the 60g pack size will remain available",
    "fr_discontinuation_comments": "Le format de l’emballage de 30g ne sera plus disponible sur le marché;  Seul le format de l’emballage de 60g restera disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-16T05:00:11-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PROTOPIC",
    "en_drug_common_name": "Tacrolimus",
    "fr_drug_brand_name": "Protopic",
    "fr_drug_common_name": "Tacrolimus",
    "en_ingredients": "TACROLIMUS",
    "fr_ingredients": "Tacrolimus",
    "drug_strength": "0.03%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255094,
    "drug": {
      "current_status": "MARKETED",
      "id": 11460,
      "drug_code": 68109,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 80,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4489,
        "mfr_code": "LEO08",
        "name": "LEO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6 ADELAIDE STREET EAST, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5C 1H6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254268,
          "ingredient": {
            "id": 2242,
            "ingredient_code": 167,
            "en_name": "TACROLIMUS",
            "fr_name": "Tacrolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02244148",
      "brand_name": "PROTOPIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127857004"
    },
    "created_date": "2025-04-15T19:18:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02244148",
    "company_name": "LEO PHARMA INC",
    "atc_number": "D11AH",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "discontinuation_date": "2025-04-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "N/A",
    "fr_supply_disruption_mitigation": "N/A",
    "en_discontinuation_comments": "The 30g pack size will no longer be available for the market;  Only the 60g pack size will remain available.",
    "fr_discontinuation_comments": "Le format de l’emballage de 30g ne sera plus disponible sur le marché;  Seul le format de l’emballage de 60g restera disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-16T05:00:11-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PROTOPIC",
    "en_drug_common_name": "Tacrolimus",
    "fr_drug_brand_name": "Protopic",
    "fr_drug_common_name": "Tacrolimus",
    "en_ingredients": "TACROLIMUS",
    "fr_ingredients": "Tacrolimus",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255099,
    "drug": {
      "current_status": "MARKETED",
      "id": 6728,
      "drug_code": 44187,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253161,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "755",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172755",
      "brand_name": "OMNIPAQUE 350",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9821",
      "number_of_ais": "1",
      "ai_group_no": "0116846006"
    },
    "created_date": "2025-04-15T20:19:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172755",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "estimated_end_date": "2025-04-30T00:00:00-04:00",
    "actual_start_date": "2025-04-15T00:00:00-04:00",
    "actual_end_date": "2025-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-05-03T05:00:14-04:00",
    "status": "resolved",
    "en_comments": "Reason for shortage - manufacturing delay",
    "fr_comments": "Raison de la pénurie - délai de fabrication",
    "en_drug_brand_name": "OMNIPAQUE 350",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 350",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "755MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Orale\r\nIntravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255147,
    "drug": {
      "current_status": "MARKETED",
      "id": 2330,
      "drug_code": 15481,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8252028,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01999869",
      "brand_name": "KENALOG-40 INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77169",
      "number_of_ais": "1",
      "ai_group_no": "0106310006"
    },
    "created_date": "2025-04-16T14:35:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01999869",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "anticipated_start_date": "2025-04-16T00:00:00-04:00",
    "estimated_end_date": "2026-04-30T00:00:00-04:00",
    "actual_start_date": "2025-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-16T20:56:49-04:00",
    "status": "active_confirmed",
    "en_comments": "The shortages are for both 5ML and 1 ML.",
    "fr_comments": "Le shortage est pour 5ML et 1ML.",
    "en_drug_brand_name": "KENALOG-40 INJECTION",
    "en_drug_common_name": "Triamcinolone Acetonide",
    "fr_drug_brand_name": "KENALOG",
    "fr_drug_common_name": "Triamcinolone Acetonide",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "40MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRA-ARTICULAR\r\nINTRAMUSCULAR\r\nINTRA-ARTICULAR",
    "drug_route_fr": "Intramusculaire\r\nIntra-articulaire\r\nIntramusculaire\r\nIntra-articulaire",
    "drug_package_quantity": "5ML & 1ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255152,
    "drug": {
      "current_status": "MARKETED",
      "id": 6726,
      "drug_code": 44186,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253160,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "647",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172747",
      "brand_name": "OMNIPAQUE 300",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9820",
      "number_of_ais": "1",
      "ai_group_no": "0116846004"
    },
    "created_date": "2025-04-16T15:00:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172747",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "estimated_end_date": "2025-04-21T00:00:00-04:00",
    "actual_start_date": "2025-04-16T00:00:00-04:00",
    "actual_end_date": "2025-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-04-22T05:00:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 300",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "omnipaque 300",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "647MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "RECTAL\r\nORAL\r\nINTRA-ARTICULAR\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Rectale\r\nOrale\r\nIntra-articulaire\r\nIntravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255162,
    "drug": {
      "current_status": "MARKETED",
      "id": 66183,
      "drug_code": 98243,
      "updated_date": "2025-05-15T02:38:32-04:00",
      "company": {
        "id": 500,
        "created_date": "2017-03-09T13:22:49-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11482,
        "mfr_code": "",
        "name": "AMPHASTAR PHARMACEUTICALS, INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11570 SIXTH STREET",
        "province": "CALIFORNIA",
        "country": "UNITED STATES",
        "city": "RANCHO CUCAMONGA",
        "postal_code": "91730",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264437,
          "ingredient": {
            "id": 30968,
            "ingredient_code": 11363,
            "en_name": "GLUCAGON",
            "fr_name": "Glucagon (Chlorhydrate de glucagon)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "CONTAINER",
          "base": false
        }
      ],
      "din": "02492415",
      "brand_name": "BAQSIMI",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE DEVICE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101772002"
    },
    "created_date": "2025-04-16T20:30:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02492415",
    "company_name": "AMPHASTAR PHARMACEUTICALS, INC.",
    "atc_number": "H04AA",
    "atc_description": "GLYCOGENOLYTIC HORMONES",
    "anticipated_start_date": "2025-04-21T00:00:00-04:00",
    "estimated_end_date": "2025-05-02T00:00:00-04:00",
    "actual_end_date": "2025-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-02T13:41:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BAQSIMI",
    "en_drug_common_name": "Glucagon Nasal Powder",
    "fr_drug_brand_name": "BAQSIMI",
    "fr_drug_common_name": "Glucagon Nasal Powder",
    "en_ingredients": "GLUCAGON",
    "fr_ingredients": "Glucagon (Chlorhydrate de glucagon)",
    "drug_strength": "3MG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "3mg glucagon per device",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255171,
    "drug": {
      "current_status": "MARKETED",
      "id": 18520,
      "drug_code": 79794,
      "updated_date": "2025-12-03T00:31:20-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8256479,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312433",
      "brand_name": "PRADAXA",
      "brand_name_fr": "",
      "descriptor": "KNOWN AS PRADAX",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467001"
    },
    "created_date": "2025-04-17T12:25:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312433",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2025-10-24T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Inventory has been depleted",
    "fr_supply_disruption_mitigation": "L'inventaire a été épuisé",
    "en_discontinuation_comments": "Pradaxa 110mg 6x10s and Pradaxa 150mg 6x10s remains available",
    "fr_discontinuation_comments": "Pradaxa 110 mg 6 x 10 et Pradaxa 150 mg 6 x 10 restent disponibles",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-10-25T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRADAXA",
    "en_drug_common_name": "Pradaxa 75mg 3x10",
    "fr_drug_brand_name": "PRADAXA",
    "fr_drug_common_name": "Pradaxa 75mg 3x10",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "Dabigatran étexilate (Mésilate de dabigatran étexilate)",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "3x10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255190,
    "drug": {
      "current_status": "MARKETED",
      "id": 30154,
      "drug_code": 92202,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261013,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "55",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02437635",
      "brand_name": "APO-TRIAMCINOLONE AQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106310010"
    },
    "created_date": "2025-04-17T14:11:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437635",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2025-05-02T00:00:00-04:00",
    "actual_start_date": "2025-04-15T00:00:00-04:00",
    "actual_end_date": "2025-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-25T19:12:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRIAMCINOLONE AQ",
    "en_drug_common_name": "TRIAMCINOLONE",
    "fr_drug_brand_name": "APO-TRIAMCINOLONE AQ",
    "fr_drug_common_name": "TRIAMCINOLONE",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "55MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "120MS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255194,
    "drug": {
      "current_status": "MARKETED",
      "id": 17032,
      "drug_code": 78059,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256007,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295288",
      "brand_name": "APO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2025-04-17T14:20:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295288",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-15T00:00:00-04:00",
    "actual_end_date": "2025-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-02T20:13:10-04:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 btl disponible",
    "en_drug_brand_name": "APO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "APO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine (Atorvastatine calcique)",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255197,
    "drug": {
      "current_status": "MARKETED",
      "id": 15526,
      "drug_code": 76152,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 1228,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 12151,
        "mfr_code": "",
        "name": "WOCKHARDT UK LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ASH ROAD NORTH, WREXHAM INDUSTRIAL ESTATE",
        "province": "--",
        "country": "UNITED KINGDOM",
        "city": "WREXHAM",
        "postal_code": "LL13 9UF",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255554,
          "ingredient": {
            "id": 3266,
            "ingredient_code": 7650,
            "en_name": "INSULIN ISOPHANE INJECTION PORK",
            "fr_name": "Insuline isophane porcine (injectable)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02275864",
      "brand_name": "HYPURIN NPH INSULIN ISOPHANE PORK",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151573001"
    },
    "created_date": "2025-04-17T14:28:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02275864",
    "company_name": "WOCKHARDT UK LIMITED",
    "atc_number": "A10AC",
    "atc_description": "INSULINS AND ANALOGUES",
    "discontinuation_date": "2026-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2025-04-17T14:28:44-04:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "HYPURIN NPH INSULIN ISOPHANE PORK",
    "en_drug_common_name": "HYPURIN NPH INSULIN ISOPHANE PORK",
    "fr_drug_brand_name": "HYPURIN NPH INSULIN ISOPHANE PORK",
    "fr_drug_common_name": "HYPURIN NPH INSULIN ISOPHANE PORK",
    "en_ingredients": "INSULIN ISOPHANE INJECTION PORK",
    "fr_ingredients": "Insuline isophane porcine (injectable)",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255200,
    "drug": {
      "current_status": "MARKETED",
      "id": 15528,
      "drug_code": 76153,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 1228,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 12151,
        "mfr_code": "",
        "name": "WOCKHARDT UK LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ASH ROAD NORTH, WREXHAM INDUSTRIAL ESTATE",
        "province": "--",
        "country": "UNITED KINGDOM",
        "city": "WREXHAM",
        "postal_code": "LL13 9UF",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255555,
          "ingredient": {
            "id": 3268,
            "ingredient_code": 7659,
            "en_name": "INSULIN INJECTION PORK",
            "fr_name": "Insuline porcine injectable"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02275872",
      "brand_name": "HYPURIN REGULAR INSULIN PORK",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151574001"
    },
    "created_date": "2025-04-17T14:29:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02275872",
    "company_name": "WOCKHARDT UK LIMITED",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "discontinuation_date": "2025-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2026-01-01T06:00:19-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYPURIN REGULAR INSULIN PORK",
    "en_drug_common_name": "HYPURIN REGULAR INSULIN PORK",
    "fr_drug_brand_name": "HYPURIN REGULAR INSULIN PORK",
    "fr_drug_common_name": "HYPURIN REGULAR INSULIN PORK",
    "en_ingredients": "INSULIN INJECTION PORK",
    "fr_ingredients": "Insuline porcine injectable",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255205,
    "drug": {
      "current_status": "MARKETED",
      "id": 13872,
      "drug_code": 73770,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254987,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02252767",
      "brand_name": "APO-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2025-04-17T14:43:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02252767",
    "company_name": "APOTEX INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2025-09-19T00:00:00-04:00",
    "actual_start_date": "2025-04-15T00:00:00-04:00",
    "actual_end_date": "2025-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-19T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Limited release",
    "en_drug_brand_name": "APO-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "APO-CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "Clopidogrel (Bisulfate de clopidogrel)",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255208,
    "drug": {
      "current_status": "MARKETED",
      "id": 14346,
      "drug_code": 74515,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255162,
          "ingredient": {
            "id": 2642,
            "ingredient_code": 11821,
            "en_name": "TIZANIDINE",
            "fr_name": "Tizanidine (Chlorhydrate de tizanidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02259893",
      "brand_name": "APO-TIZANIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135342001"
    },
    "created_date": "2025-04-17T14:44:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02259893",
    "company_name": "APOTEX INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "estimated_end_date": "2025-06-20T00:00:00-04:00",
    "actual_start_date": "2025-04-15T00:00:00-04:00",
    "actual_end_date": "2025-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TIZANIDINE",
    "en_drug_common_name": "TIZANIDINE",
    "fr_drug_brand_name": "APO-TIZANIDINE",
    "fr_drug_common_name": "TIZANIDINE",
    "en_ingredients": "TIZANIDINE",
    "fr_ingredients": "Tizanidine (Chlorhydrate de tizanidine)",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255211,
    "drug": {
      "current_status": "MARKETED",
      "id": 11518,
      "drug_code": 68278,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254285,
          "ingredient": {
            "id": 2918,
            "ingredient_code": 11777,
            "en_name": "SEVELAMER HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sévélamer"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244310",
      "brand_name": "RENAGEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0139865002"
    },
    "created_date": "2025-04-17T15:16:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244310",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "V03AE",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2025-08-31T00:00:00-04:00",
    "actual_start_date": "2025-04-15T00:00:00-04:00",
    "actual_end_date": "2025-08-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-08-30T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Demand. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "Demande. La date de disponibilité représente une estimation de la disponibilité à l’entrepôt principal de Sanofi. Les dates de disponibilité à l’entrepôt du distributeur habituel d’un client peuvent varier. Les pharmacies sont invitées à communiquer avec leur distributeur préféré pour obtenir la date de disponibilité du produit. Les patients doivent vérifier la disponibilité du produit auprès de leur pharmacie respective.",
    "en_drug_brand_name": "RENAGEL",
    "en_drug_common_name": "Sevelamer Hydrochloride",
    "fr_drug_brand_name": "RENAGEL",
    "fr_drug_common_name": "Chlorhydrate de sévélamer",
    "en_ingredients": "SEVELAMER HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sévélamer",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "180",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255222,
    "drug": {
      "current_status": "MARKETED",
      "id": 2682,
      "drug_code": 1649,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250291,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250290,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250289,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00263818",
      "brand_name": "COTAZYM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "42494",
      "number_of_ais": "3",
      "ai_group_no": "0302964032"
    },
    "created_date": "2025-04-17T18:34:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00263818",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2025-04-30T00:00:00-04:00",
    "actual_start_date": "2025-04-17T00:00:00-04:00",
    "actual_end_date": "2025-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-04-26T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COTAZYM",
    "en_drug_common_name": "PANCRELIPASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "35000UNIT\r\n40000UNIT\r\n10000UNIT",
    "drug_dosage_form": "CAPSULE (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération immédiate)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255235,
    "drug": {
      "current_status": "MARKETED",
      "id": 6174,
      "drug_code": 42921,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253004,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8253003,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02189054",
      "brand_name": "BREVICON 1/35 TABLETS (21-DAY PACK)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9112",
      "number_of_ais": "2",
      "ai_group_no": "0210010002"
    },
    "created_date": "2025-04-17T19:28:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02189054",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "actual_start_date": "2025-05-20T00:00:00-04:00",
    "actual_end_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-01T16:33:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BREVICON 1/35 TABLETS (21-DAY PACK)",
    "en_drug_common_name": "BREVICON",
    "fr_drug_brand_name": "BREVICON",
    "fr_drug_common_name": "BREVICON",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nNORETHINDRONE",
    "fr_ingredients": "Éthinylestradiol\r\nNoréthindrone",
    "drug_strength": "0.035MG\r\n1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255238,
    "drug": {
      "current_status": "MARKETED",
      "id": 6162,
      "drug_code": 42888,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252992,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": ".035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252991,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": ".5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02187094",
      "brand_name": "BREVICON 0.5/35 TABLETS (28-DAY PACK)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9073",
      "number_of_ais": "2",
      "ai_group_no": "0210010001"
    },
    "created_date": "2025-04-17T19:32:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187094",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2026-05-29T00:00:00-04:00",
    "actual_start_date": "2025-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-02T19:42:26-04:00",
    "status": "active_confirmed",
    "en_comments": "Availability with 21-day pack",
    "fr_comments": "Disponibilité de la boite de 21",
    "en_drug_brand_name": "BREVICON 0.5/35 TABLETS (28-DAY PACK)",
    "en_drug_common_name": "BREVICON",
    "fr_drug_brand_name": "BREVICON",
    "fr_drug_common_name": "BREVICON",
    "en_ingredients": "NORETHINDRONE\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Noréthindrone\r\nÉthinylestradiol",
    "drug_strength": ".5MG\r\n.035MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255257,
    "drug": {
      "current_status": "MARKETED",
      "id": 282,
      "drug_code": 10770,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251383,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00821780",
      "brand_name": "CALCIJECT INJ 100MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70811",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2025-04-21T15:24:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00821780",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2025-05-25T00:00:00-04:00",
    "estimated_end_date": "2026-01-09T00:00:00-05:00",
    "actual_start_date": "2025-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-17T20:39:37-05:00",
    "status": "active_confirmed",
    "en_comments": "Product on allocation.",
    "fr_comments": "Le produit est en allocation.",
    "en_drug_brand_name": "CALCIJECT INJ 100MG/ML",
    "en_drug_common_name": "Calcium Chloride Injection",
    "fr_drug_brand_name": "CALCIJECT INJ 100MG/ML",
    "fr_drug_common_name": "Chlorure de calcium",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50 mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255260,
    "drug": {
      "current_status": "MARKETED",
      "id": 5474,
      "drug_code": 36480,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252846,
          "ingredient": {
            "id": 304,
            "ingredient_code": 12030,
            "en_name": "DEXAMETHASONE PHOSPHATE",
            "fr_name": "Phosphate de dexaméthasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02204266",
      "brand_name": "DEXAMETHASONE-OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3818",
      "number_of_ais": "1",
      "ai_group_no": "0106305003"
    },
    "created_date": "2025-04-21T15:26:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02204266",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "anticipated_start_date": "2025-08-26T00:00:00-04:00",
    "estimated_end_date": "2025-10-17T00:00:00-04:00",
    "actual_start_date": "2025-08-29T00:00:00-04:00",
    "actual_end_date": "2025-10-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-07T13:12:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXAMETHASONE-OMEGA",
    "en_drug_common_name": "DEXAMETHASONE PHOSPHATE INJECTION",
    "fr_drug_brand_name": "DEXAMETHASONE-OMEGA",
    "fr_drug_common_name": "Phosphate de dexaméthasone",
    "en_ingredients": "DEXAMETHASONE PHOSPHATE",
    "fr_ingredients": "Phosphate de dexaméthasone (Phosphate de dexaméthasone sodique)",
    "drug_strength": "4MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SOFT TISSUE INJECTION\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR\r\nSOFT TISSUE INJECTION\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR",
    "drug_route_fr": "Injection dans les tissus mous\r\nIntraveineuse\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire\r\nInjection dans les tissus mous\r\nIntraveineuse\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire",
    "drug_package_quantity": "10 X 25 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255263,
    "drug": {
      "current_status": "MARKETED",
      "id": 1980,
      "drug_code": 14183,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251925,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251924,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02020939",
      "brand_name": "SCLERODEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75705",
      "number_of_ais": "2",
      "ai_group_no": "0200203010"
    },
    "created_date": "2025-04-21T15:29:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02020939",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "C05BB",
    "atc_description": "ANTIVARICOSE THERAPY",
    "anticipated_start_date": "2025-04-21T00:00:00-04:00",
    "estimated_end_date": "2025-09-05T00:00:00-04:00",
    "actual_start_date": "2025-04-21T00:00:00-04:00",
    "actual_end_date": "2025-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-28T19:19:47-04:00",
    "status": "resolved",
    "en_comments": "Stock available in packs of 10 vials (Product code L0010035)",
    "fr_comments": "Stock disponible en boîtes de 10 fioles (code produit L0010035)",
    "en_drug_brand_name": "SCLERODEX",
    "en_drug_common_name": "DEXTROSE AND SODIUM CHLORIDE",
    "fr_drug_brand_name": "SCLERODEX",
    "fr_drug_common_name": "Dextrose et Chlorure de sodium",
    "en_ingredients": "SODIUM CHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "Chlorure de sodium\r\nDextrose",
    "drug_strength": "100MG\r\n250MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 X 10 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255266,
    "drug": {
      "current_status": "MARKETED",
      "id": 101731,
      "drug_code": 100327,
      "updated_date": "2021-04-08T05:03:54-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8266202,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02514095",
      "brand_name": "DILTIAZEM HYDROCHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863003"
    },
    "created_date": "2025-04-21T15:31:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02514095",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2025-07-14T00:00:00-04:00",
    "estimated_end_date": "2025-11-30T00:00:00-05:00",
    "actual_start_date": "2025-07-14T00:00:00-04:00",
    "actual_end_date": "2025-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-25T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Product will remain on allocation.",
    "fr_comments": "Le produit restera en allocation.",
    "en_drug_brand_name": "DILTIAZEM HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "DILTIAZEM HYDROCHLORIDE",
    "fr_drug_brand_name": "DILTIAZEM HYDROCHLORIDE INJECTION",
    "fr_drug_common_name": "Chlorhydrate de diltiazem",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 5 mL & 10 x 10 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255271,
    "drug": {
      "current_status": "MARKETED",
      "id": 5596,
      "drug_code": 37198,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252894,
          "ingredient": {
            "id": 144,
            "ingredient_code": 182,
            "en_name": "DIPHENHYDRAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diphénhydramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02219336",
      "brand_name": "DIPHENIST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4674",
      "number_of_ais": "1",
      "ai_group_no": "0102639001"
    },
    "created_date": "2025-04-21T15:34:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02219336",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "R06AA",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "anticipated_start_date": "2025-08-31T00:00:00-04:00",
    "estimated_end_date": "2025-09-30T00:00:00-04:00",
    "actual_end_date": "2025-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-09T14:14:23-04:00",
    "status": "avoided_shortage",
    "en_comments": "We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact.",
    "fr_comments": "Nous collaborons actuellement avec l'Unité des pénuries de médicaments de Santé Canada afin d'atténuer tout impact sur le marché",
    "en_drug_brand_name": "DIPHENIST",
    "en_drug_common_name": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "fr_drug_brand_name": "DIPHENIST",
    "fr_drug_common_name": "Chlorhydrate de diphénhydramine",
    "en_ingredients": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diphénhydramine",
    "drug_strength": "50MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255274,
    "drug": {
      "current_status": "MARKETED",
      "id": 12886,
      "drug_code": 72026,
      "updated_date": "2025-05-15T02:31:27-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254720,
          "ingredient": {
            "id": 916,
            "ingredient_code": 1395,
            "en_name": "FAMOTIDINE",
            "fr_name": "Famotidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247745",
      "brand_name": "FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118722003"
    },
    "created_date": "2025-04-21T15:35:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247745",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2025-09-30T00:00:00-04:00",
    "estimated_end_date": "2025-10-31T00:00:00-04:00",
    "actual_start_date": "2025-10-03T00:00:00-04:00",
    "actual_end_date": "2025-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-16T14:04:11-04:00",
    "status": "resolved",
    "en_comments": "Product available at CPDN",
    "fr_comments": "Produit disponible chez CPDN",
    "en_drug_brand_name": "FAMOTIDINE OMEGA   -(WITH PRESERVATIVE,BENZYL ALCOHOL)",
    "en_drug_common_name": "FAMOTIDINE",
    "fr_drug_brand_name": "FAMOTIDINE OMEGA -(PRESERVATIVE,BENZYL ALCOHOL)",
    "fr_drug_common_name": "Famotidine",
    "en_ingredients": "FAMOTIDINE",
    "fr_ingredients": "Famotidine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 X 20 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255277,
    "drug": {
      "current_status": "MARKETED",
      "id": 19508,
      "drug_code": 80824,
      "updated_date": "2025-12-03T00:31:24-05:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8256816,
          "ingredient": {
            "id": 3446,
            "ingredient_code": 11382,
            "en_name": "GRANISETRON",
            "fr_name": "Granisétron (Chlorhydrate de granisétron)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02322765",
      "brand_name": "GRANISETRON HYDROCHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123183001"
    },
    "created_date": "2025-04-21T15:37:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02322765",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2025-06-20T00:00:00-04:00",
    "estimated_end_date": "2025-07-14T00:00:00-04:00",
    "actual_start_date": "2025-06-20T00:00:00-04:00",
    "actual_end_date": "2025-07-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-16T19:33:21-04:00",
    "status": "resolved",
    "en_comments": "Some stock available at CPDN.",
    "fr_comments": "Inventaire limité disponible au CPDN",
    "en_drug_brand_name": "GRANISETRON HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "GRANISETRON HYDROCHLORIDE INJECTION",
    "fr_drug_brand_name": "GRANISETRON HYDROCHLORIDE INJECTION",
    "fr_drug_common_name": "Chlorhydrate de granisétron",
    "en_ingredients": "GRANISETRON",
    "fr_ingredients": "Granisétron (Chlorhydrate de granisétron)",
    "drug_strength": "1MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255280,
    "drug": {
      "current_status": "MARKETED",
      "id": 101250,
      "drug_code": 99778,
      "updated_date": "2020-12-09T00:57:58-05:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8265845,
          "ingredient": {
            "id": 1754,
            "ingredient_code": 9008,
            "en_name": "HYOSCINE BUTYLBROMIDE",
            "fr_name": "Butylbromure d'hyoscine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02508419",
      "brand_name": "HYOSCINE BUTYLBROMIDE INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104703002"
    },
    "created_date": "2025-04-21T15:39:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02508419",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "A03BB",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "anticipated_start_date": "2025-06-30T00:00:00-04:00",
    "estimated_end_date": "2025-10-31T00:00:00-04:00",
    "actual_start_date": "2025-06-30T00:00:00-04:00",
    "actual_end_date": "2025-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-24T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Sandoz is covering Juno's hospital contracts.",
    "fr_comments": "Sandoz couvre les contrats hospitaliers de Juno.",
    "en_drug_brand_name": "HYOSCINE BUTYLBROMIDE INJECTION BP",
    "en_drug_common_name": "HYOSCINE BUTYLBROMIDE",
    "fr_drug_brand_name": "HYOSCINE BUTYLBROMIDE INJECTION BP",
    "fr_drug_common_name": "Butylbromure d'hyoscine",
    "en_ingredients": "HYOSCINE BUTYLBROMIDE",
    "fr_ingredients": "Butylbromure d'hyoscine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255283,
    "drug": {
      "current_status": "MARKETED",
      "id": 14646,
      "drug_code": 74932,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8255264,
          "ingredient": {
            "id": 2664,
            "ingredient_code": 9543,
            "en_name": "METHACHOLINE CHLORIDE",
            "fr_name": "Chlorure de méthacholine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02263912",
      "brand_name": "METHACHOLINE OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136042007"
    },
    "created_date": "2025-04-21T15:40:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02263912",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "V04CX",
    "atc_description": "OTHER DIAGNOSTIC AGENTS",
    "anticipated_start_date": "2025-06-06T00:00:00-04:00",
    "estimated_end_date": "2025-09-12T00:00:00-04:00",
    "actual_start_date": "2025-06-06T00:00:00-04:00",
    "actual_end_date": "2025-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-04T14:25:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHACHOLINE OMEGA",
    "en_drug_common_name": "METHACHOLINE CHLORIDE",
    "fr_drug_brand_name": "METHACHOLINE OMEGA",
    "fr_drug_common_name": "Chlorure de méthacholine",
    "en_ingredients": "METHACHOLINE CHLORIDE",
    "fr_ingredients": "Chlorure de méthacholine",
    "drug_strength": "1600MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1 x 50 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255286,
    "drug": {
      "current_status": "MARKETED",
      "id": 7436,
      "drug_code": 50032,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8253311,
          "ingredient": {
            "id": 58,
            "ingredient_code": 7160,
            "en_name": "METHYLENE BLUE",
            "fr_name": "Bleu de méthylène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230770",
      "brand_name": "METHYLENE BLUE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106816001"
    },
    "created_date": "2025-04-21T15:42:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230770",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2025-04-21T00:00:00-04:00",
    "estimated_end_date": "2025-08-04T00:00:00-04:00",
    "actual_start_date": "2025-04-30T00:00:00-04:00",
    "actual_end_date": "2025-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-02T05:00:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHYLENE BLUE INJECTION USP",
    "en_drug_common_name": "METHYLENE BLUE",
    "fr_drug_brand_name": "METHYLENE BLUE INJECTION USP",
    "fr_drug_common_name": "Bleu de méthylène",
    "en_ingredients": "METHYLENE BLUE",
    "fr_ingredients": "Bleu de méthylène",
    "drug_strength": "10MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 5 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255289,
    "drug": {
      "current_status": "MARKETED",
      "id": 5470,
      "drug_code": 36404,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252845,
          "ingredient": {
            "id": 1248,
            "ingredient_code": 298,
            "en_name": "MINERAL OIL LIGHT",
            "fr_name": "Huile minérale  légère"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "V/V",
          "base": false
        }
      ],
      "din": "02203375",
      "brand_name": "STERILE LIGHT MINERAL OIL 100%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3737",
      "number_of_ais": "1",
      "ai_group_no": "0126693001"
    },
    "created_date": "2025-04-21T15:43:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02203375",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "D02AC",
    "atc_description": "EMOLLIENTS AND PROTECTIVES",
    "anticipated_start_date": "2025-09-20T00:00:00-04:00",
    "actual_end_date": "2025-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-17T15:31:41-04:00",
    "status": "avoided_shortage",
    "en_comments": "No backorder expected",
    "en_drug_brand_name": "STERILE LIGHT MINERAL OIL 100%",
    "en_drug_common_name": "MINERAL OIL LIGHT STERILE",
    "fr_drug_brand_name": "STERILE LIGHT MINERAL OIL 100%",
    "fr_drug_common_name": "Huile minérale légère",
    "en_ingredients": "MINERAL OIL LIGHT",
    "fr_ingredients": "Huile minérale  légère",
    "drug_strength": "100%",
    "drug_dosage_form": "OIL",
    "drug_dosage_form_fr": "Huile",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "10 x 30 mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255294,
    "drug": {
      "current_status": "MARKETED",
      "id": 13624,
      "drug_code": 73449,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254924,
          "ingredient": {
            "id": 2928,
            "ingredient_code": 896,
            "en_name": "PAMIDRONATE DISODIUM",
            "fr_name": "Pamidronate disodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02249685",
      "brand_name": "PAMIDRONATE DISODIUM OMEGA 9 MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123608006"
    },
    "created_date": "2025-04-21T15:45:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249685",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "anticipated_start_date": "2025-10-13T00:00:00-04:00",
    "estimated_end_date": "2025-10-24T00:00:00-04:00",
    "actual_end_date": "2025-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-16T14:03:19-04:00",
    "status": "resolved",
    "fr_comments": "Produit en allocation.",
    "en_drug_brand_name": "PAMIDRONATE DISODIUM OMEGA 9 MG/ML",
    "en_drug_common_name": "PAMIDRONATE DISODIUM",
    "fr_drug_brand_name": "PAMIDRONATE DISODIUM OMEGA 9 MG/ML",
    "fr_drug_common_name": "Pamidronate disodique",
    "en_ingredients": "PAMIDRONATE DISODIUM",
    "fr_ingredients": "Pamidronate disodique",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 10 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255301,
    "drug": {
      "current_status": "MARKETED",
      "id": 9090,
      "drug_code": 61817,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8253574,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238400",
      "brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100662004"
    },
    "created_date": "2025-04-21T15:46:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238400",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2025-07-21T00:00:00-04:00",
    "estimated_end_date": "2025-09-15T00:00:00-04:00",
    "actual_start_date": "2025-06-17T00:00:00-04:00",
    "actual_end_date": "2025-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-11T17:26:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%",
    "fr_drug_common_name": "Chlorhydrate de phényléphrine",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255306,
    "drug": {
      "current_status": "MARKETED",
      "id": 22364,
      "drug_code": 84760,
      "updated_date": "2025-12-03T00:31:44-05:00",
      "company": {
        "id": 17393,
        "created_date": "2025-12-03T00:30:14-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 22004,
        "mfr_code": "",
        "name": "JUNO PHARMA CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258008,
          "ingredient": {
            "id": 1166,
            "ingredient_code": 1076,
            "en_name": "POTASSIUM ACETATE",
            "fr_name": "Acétate de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "39.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02362597",
      "brand_name": "POTASSIUM ACETATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "POTASSIUM 4MMOL/ML. 50ML SINGLE USE VIALS.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107304002"
    },
    "created_date": "2025-04-21T15:48:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362597",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2025-07-14T00:00:00-04:00",
    "estimated_end_date": "2025-08-11T00:00:00-04:00",
    "actual_start_date": "2025-07-14T00:00:00-04:00",
    "actual_end_date": "2025-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-11T17:24:40-04:00",
    "status": "resolved",
    "en_comments": "We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact. Product on allocation.",
    "fr_comments": "Nous collaborons actuellement avec l'Unité des pénuries de médicaments de Santé Canada afin d'atténuer tout impact sur le marché. Produit en allocation.",
    "en_drug_brand_name": "POTASSIUM ACETATE INJECTION USP",
    "en_drug_common_name": "POTASSIUM ACETATE",
    "fr_drug_brand_name": "POTASSIUM ACETATE INJECTION USP",
    "fr_drug_common_name": "Acétate de potassium",
    "en_ingredients": "POTASSIUM ACETATE",
    "fr_ingredients": "Acétate de potassium",
    "drug_strength": "39.2%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255309,
    "drug": {
      "current_status": "MARKETED",
      "id": 25322,
      "drug_code": 87801,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8259177,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02392763",
      "brand_name": "TRANEXAMIC ACID INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2025-04-21T15:50:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392763",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B02AA",
    "atc_description": "ANTIFIBRINOLYTICS",
    "anticipated_start_date": "2025-07-01T00:00:00-04:00",
    "estimated_end_date": "2025-09-22T00:00:00-04:00",
    "actual_start_date": "2025-07-01T00:00:00-04:00",
    "actual_end_date": "2025-09-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-06T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION",
    "en_drug_common_name": "TRANEXAMIC ACID",
    "fr_drug_brand_name": "TRANEXAMIC ACID INJECTION",
    "fr_drug_common_name": "Acide tranexamique",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 50 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255312,
    "drug": {
      "current_status": "MARKETED",
      "id": 5272,
      "drug_code": 3396,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250509,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402249",
      "brand_name": "SODIUM CHLORIDE BACTERIOSTATIC INJ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54173",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2025-04-21T15:52:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402249",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2025-10-31T00:00:00-04:00",
    "actual_end_date": "2025-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-16T14:33:34-04:00",
    "status": "avoided_shortage",
    "en_comments": "Product on allocation.",
    "fr_comments": "Produit en allocation.",
    "en_drug_brand_name": "SODIUM CHLORIDE BACTERIOSTATIC INJ",
    "en_drug_common_name": "SODIUM CHLORIDE BACTERIOSTATIC INJECTION 0.9%",
    "fr_drug_brand_name": "SODIUM CHLORIDE BACTERIOSTATIC INJ",
    "fr_drug_common_name": "CHLORURE DE SODIUM INJECTION BACT. 0.9%",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 30 mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255391,
    "drug": {
      "current_status": "MARKETED",
      "id": 25102,
      "drug_code": 87611,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259095,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "145.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390701",
      "brand_name": "SANDOZ FENOFIBRATE E",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895006"
    },
    "created_date": "2025-04-22T12:59:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390701",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-21T00:00:00-04:00",
    "actual_end_date": "2025-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-05-20T13:09:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENOFIBRATE E",
    "en_drug_common_name": "FENOFIBRATE E",
    "fr_drug_brand_name": "SANDOZ FENOFIBRATE E",
    "fr_drug_common_name": "FENOFIBRATE E",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "145.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255396,
    "drug": {
      "current_status": "MARKETED",
      "id": 6728,
      "drug_code": 44187,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253161,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "755",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172755",
      "brand_name": "OMNIPAQUE 350",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9821",
      "number_of_ais": "1",
      "ai_group_no": "0116846006"
    },
    "created_date": "2025-04-22T17:07:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172755",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2025-04-22T00:00:00-04:00",
    "estimated_end_date": "2025-04-29T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-04-29T05:00:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 350",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "omnipaque 350",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "755MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Orale\r\nIntravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255406,
    "drug": {
      "current_status": "MARKETED",
      "id": 10792,
      "drug_code": 66607,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254081,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242784",
      "brand_name": "MYLAN-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506002"
    },
    "created_date": "2025-04-23T12:05:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242784",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2025-05-20T00:00:00-04:00",
    "estimated_end_date": "2025-07-16T00:00:00-04:00",
    "actual_start_date": "2025-05-15T00:00:00-04:00",
    "actual_end_date": "2025-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-21T18:54:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir (Acyclovir sodique)",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255409,
    "drug": {
      "current_status": "MARKETED",
      "id": 26354,
      "drug_code": 88703,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259520,
          "ingredient": {
            "id": 2578,
            "ingredient_code": 11782,
            "en_name": "PROGUANIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de proguanil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259519,
          "ingredient": {
            "id": 2152,
            "ingredient_code": 8317,
            "en_name": "ATOVAQUONE",
            "fr_name": "Atovaquone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402165",
      "brand_name": "MYLAN-ATOVAQUONE/PROGUANIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250721002"
    },
    "created_date": "2025-04-23T12:06:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402165",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "P01BB",
    "atc_description": "ANTIMALARIALS",
    "anticipated_start_date": "2025-05-05T00:00:00-04:00",
    "estimated_end_date": "2025-10-20T00:00:00-04:00",
    "actual_start_date": "2025-05-05T00:00:00-04:00",
    "actual_end_date": "2025-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2025-10-28T18:37:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ATOVAQUONE/PROGUANIL",
    "en_drug_common_name": "ATOVAQUONE/PROGUANIL",
    "fr_drug_brand_name": "MYLAN-ATOVAQUONE/PROGUANIL",
    "fr_drug_common_name": "ATOVAQUONE/PROGUANIL",
    "en_ingredients": "PROGUANIL HYDROCHLORIDE\r\nATOVAQUONE",
    "fr_ingredients": "Chlorhydrate de proguanil\r\nAtovaquone",
    "drug_strength": "100MG\r\n250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255412,
    "drug": {
      "current_status": "MARKETED",
      "id": 66095,
      "drug_code": 95854,
      "updated_date": "2025-12-03T00:33:34-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262850,
          "ingredient": {
            "id": 3710,
            "ingredient_code": 20671,
            "en_name": "FINGOLIMOD",
            "fr_name": "Fingolimod (Chlorhydrate de Fingolimod)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469715",
      "brand_name": "MYLAN-FINGOLIMOD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152886001"
    },
    "created_date": "2025-04-23T12:07:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469715",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "L04AE",
    "anticipated_start_date": "2025-07-06T00:00:00-04:00",
    "actual_start_date": "2025-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-23T14:21:55-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MYLAN-FINGOLIMOD",
    "en_drug_common_name": "FINGOLIMOD",
    "fr_drug_brand_name": "MYLAN-FINGOLIMOD",
    "fr_drug_common_name": "FINGOLIMOD",
    "en_ingredients": "FINGOLIMOD",
    "fr_ingredients": "Fingolimod (Chlorhydrate de Fingolimod)",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28BL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255415,
    "drug": {
      "current_status": "MARKETED",
      "id": 22392,
      "drug_code": 84778,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8258025,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258024,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362783",
      "brand_name": "MYLAN-AMLODIPINE/ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555004"
    },
    "created_date": "2025-04-23T12:09:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362783",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "anticipated_start_date": "2025-05-27T00:00:00-04:00",
    "estimated_end_date": "2025-07-18T00:00:00-04:00",
    "actual_start_date": "2025-05-28T00:00:00-04:00",
    "actual_end_date": "2025-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-07-21T19:02:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-AMLODIPINE/ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "fr_drug_brand_name": "MYLAN-AMLODIPINE/ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "Atorvastatine (Atorvastatine calcique)\r\nAmlodipine (Bésylate d'amlodipine)",
    "drug_strength": "80MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x90BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255422,
    "drug": {
      "current_status": "MARKETED",
      "id": 55361,
      "drug_code": 94424,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262095,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457164",
      "brand_name": "MYLAN-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258002"
    },
    "created_date": "2025-04-23T12:11:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457164",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2025-05-21T00:00:00-04:00",
    "estimated_end_date": "2025-07-03T00:00:00-04:00",
    "actual_start_date": "2025-05-23T00:00:00-04:00",
    "actual_end_date": "2025-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-07T18:37:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "MYLAN-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255425,
    "drug": {
      "current_status": "MARKETED",
      "id": 27282,
      "drug_code": 89533,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259855,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410664",
      "brand_name": "MYLAN-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2025-04-23T12:13:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410664",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2025-04-29T00:00:00-04:00",
    "estimated_end_date": "2025-09-26T00:00:00-04:00",
    "actual_start_date": "2025-05-05T00:00:00-04:00",
    "actual_end_date": "2025-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-20T18:09:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "MYLAN-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255428,
    "drug": {
      "current_status": "MARKETED",
      "id": 52199,
      "drug_code": 93899,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261815,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452634",
      "brand_name": "MYLAN-TENOFOVIR DISOPROXIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152569001"
    },
    "created_date": "2025-04-23T12:15:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452634",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2025-05-10T00:00:00-04:00",
    "actual_start_date": "2025-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-23T14:26:50-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MYLAN-TENOFOVIR DISOPROXIL",
    "en_drug_common_name": "TENOFOVIR DISOPROXIL",
    "fr_drug_brand_name": "MYLAN-TENOFOVIR DISOPROXIL",
    "fr_drug_common_name": "TENOFOVIR DISOPROXIL",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255443,
    "drug": {
      "current_status": "MARKETED",
      "id": 6136,
      "drug_code": 42846,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252984,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184435",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9013",
      "number_of_ais": "1",
      "ai_group_no": "0104545002"
    },
    "created_date": "2025-04-23T12:19:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184435",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2025-04-29T00:00:00-04:00",
    "estimated_end_date": "2025-06-03T00:00:00-04:00",
    "actual_start_date": "2025-05-12T00:00:00-04:00",
    "actual_end_date": "2025-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-17T13:11:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "MORPHINE SULFATE",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255448,
    "drug": {
      "current_status": "MARKETED",
      "id": 100248,
      "drug_code": 98602,
      "updated_date": "2020-04-03T06:54:32-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8264807,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02496143",
      "brand_name": "FENTANYL INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302002"
    },
    "created_date": "2025-04-23T14:18:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496143",
    "company_name": "STERIMAX INC",
    "atc_number": "N01AH",
    "atc_description": "ANESTHETICS, GENERAL",
    "estimated_end_date": "2025-06-13T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-03T14:28:10-04:00",
    "status": "resolved",
    "en_comments": "Limited SteriMax inventory remains at McKesson.  Contract coverage is in place.",
    "fr_comments": "Inventaire est disponible en quantité limitée chez McKesson.  Couverture de contrat est en place.",
    "en_drug_brand_name": "FENTANYL INJECTION BP",
    "en_drug_common_name": "FENTANYL INJECTION BP",
    "fr_drug_brand_name": "FENTANYL INJECTION BP",
    "fr_drug_common_name": "FENTANYL INJECTION BP",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl (Citrate de fentanyl)",
    "drug_strength": "100MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nEPIDURAL",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nÉpidurale",
    "drug_package_quantity": "10 AMPOULES X 2 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255472,
    "drug": {
      "current_status": "MARKETED",
      "id": 2636,
      "drug_code": 16275,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252109,
          "ingredient": {
            "id": 214,
            "ingredient_code": 7624,
            "en_name": "METHYLPREDNISOLONE ACETATE",
            "fr_name": "Acétate de méthylprednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01934333",
      "brand_name": "DEPO-MEDROL",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "78157",
      "number_of_ais": "1",
      "ai_group_no": "0106292002"
    },
    "created_date": "2025-04-23T17:45:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01934333",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "actual_start_date": "2025-06-30T00:00:00-04:00",
    "actual_end_date": "2025-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML",
    "en_drug_common_name": "DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML",
    "fr_drug_brand_name": "DEPO-MEDROL (AVEC PRESERVATIF) 40 MG/ML",
    "fr_drug_common_name": "DEPO-MEDROL (AVEC PRESERVATIF) 40 MG/ML",
    "en_ingredients": "METHYLPREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de méthylprednisolone",
    "drug_strength": "40MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRASYNOVIAL\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR\r\nINTRASYNOVIAL\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR",
    "drug_route_fr": "Intrasynoviale\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire\r\nIntrasynoviale\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire",
    "drug_package_quantity": "5X2 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255475,
    "drug": {
      "current_status": "MARKETED",
      "id": 11230,
      "drug_code": 67616,
      "updated_date": "2025-05-15T02:31:15-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8254214,
          "ingredient": {
            "id": 2880,
            "ingredient_code": 12110,
            "en_name": "LINEZOLID",
            "fr_name": "Linézolide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243686",
      "brand_name": "ZYVOXAM",
      "brand_name_fr": "",
      "descriptor": "3G PER BOTTLE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143501006"
    },
    "created_date": "2025-04-23T17:50:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243686",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J01XX",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2025-06-30T00:00:00-04:00",
    "actual_end_date": "2025-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-05T06:00:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZYVOXAM",
    "en_drug_common_name": "ZYVOXAM",
    "fr_drug_brand_name": "ZYVOXAM",
    "fr_drug_common_name": "ZYVOXAM",
    "en_ingredients": "LINEZOLID",
    "fr_ingredients": "Linézolide",
    "drug_strength": "100MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "240ML BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255480,
    "drug": {
      "current_status": "MARKETED",
      "id": 19542,
      "drug_code": 80876,
      "updated_date": "2025-05-15T02:32:21-04:00",
      "company": {
        "id": 202,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 4225,
        "mfr_code": "GAC08",
        "name": "GALDERMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 400",
        "street_name": "55 COMMERCE VALLEY DRIVE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "THORNHILL",
        "postal_code": "L3T 7V9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256827,
          "ingredient": {
            "id": 3536,
            "ingredient_code": 20439,
            "en_name": "METHYL AMINOLEVULINATE",
            "fr_name": "Aminolévulinate méthylique (Chlorhydrate d'aminolévulinate méthylique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "168",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02323273",
      "brand_name": "METVIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152538002"
    },
    "created_date": "2025-04-23T18:52:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02323273",
    "company_name": "GALDERMA CANADA INC",
    "atc_number": "L01XD",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2025-05-27T00:00:00-04:00",
    "actual_start_date": "2025-04-23T00:00:00-04:00",
    "actual_end_date": "2025-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-27T17:45:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METVIX",
    "en_drug_common_name": "METHYL AMINOLEVULINATE",
    "fr_drug_brand_name": "METVIX",
    "fr_drug_common_name": "METHYL AMINOLEVULINATE",
    "en_ingredients": "METHYL AMINOLEVULINATE",
    "fr_ingredients": "Aminolévulinate méthylique (Chlorhydrate d'aminolévulinate méthylique)",
    "drug_strength": "168MG",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "2g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255536,
    "drug": {
      "current_status": "MARKETED",
      "id": 22412,
      "drug_code": 84797,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258041,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362996",
      "brand_name": "SANDOZ ZOLMITRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2025-04-24T15:49:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362996",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2024-06-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-24T15:49:48-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "SANDOZ ZOLMITRIPTAN ODT",
    "en_drug_common_name": "ZOLMITRIPTAN ODT",
    "fr_drug_brand_name": "SANDOZ ZOLMITRIPTAN ODT",
    "fr_drug_common_name": "ZOLMITRIPTAN ODT",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6ODT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255554,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24780,
      "drug_code": 87336,
      "updated_date": "2025-12-03T01:30:11-05:00",
      "company": {
        "id": 17301,
        "created_date": "2023-11-16T01:00:07-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 18957,
        "mfr_code": "",
        "name": "SUMITOMO PHARMA CANADA, INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "301",
        "street_name": "7025 LANGER DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0E8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351726,
          "ingredient": {
            "id": 3800,
            "ingredient_code": 21372,
            "en_name": "LURASIDONE HYDROCHLORIDE",
            "fr_name": "chlorhydrate de lurasidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387786",
      "brand_name": "LATUDA",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153185003"
    },
    "created_date": "2025-04-24T17:25:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02387786",
    "company_name": "SUMITOMO PHARMA CANADA, INC.",
    "atc_number": "N05AE",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2025-08-19T00:00:00-04:00",
    "anticipated_discontinuation_date": "2025-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-08-20T19:15:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LATUDA",
    "en_drug_common_name": "lurasidone hydrochloride tablets",
    "fr_drug_brand_name": "Latuda",
    "fr_drug_common_name": "comprimés chlorhydrate de lurasidone",
    "en_ingredients": "LURASIDONE HYDROCHLORIDE",
    "fr_ingredients": "chlorhydrate de lurasidone",
    "drug_strength": "120MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255669,
    "drug": {
      "current_status": "MARKETED",
      "id": 8738,
      "drug_code": 60693,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253519,
          "ingredient": {
            "id": 286,
            "ingredient_code": 1204,
            "en_name": "FLUCONAZOLE",
            "fr_name": "Fluconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237370",
      "brand_name": "APO-FLUCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122529001"
    },
    "created_date": "2025-04-24T19:09:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237370",
    "company_name": "APOTEX INC",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2025-05-09T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-02T20:13:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUCONAZOLE",
    "en_drug_common_name": "FLUCONAZOLE",
    "fr_drug_brand_name": "APO-FLUCONAZOLE",
    "fr_drug_common_name": "FLUCONAZOLE",
    "en_ingredients": "FLUCONAZOLE",
    "fr_ingredients": "Fluconazole",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255672,
    "drug": {
      "current_status": "MARKETED",
      "id": 11496,
      "drug_code": 6824,
      "updated_date": "2025-05-15T02:30:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250955,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250954,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00621463",
      "brand_name": "TEVA-LENOLTEC NO. 4",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64155",
      "number_of_ais": "2",
      "ai_group_no": "0211376001"
    },
    "created_date": "2025-04-24T19:18:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00621463",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2025-11-30T00:00:00-05:00",
    "actual_start_date": "2025-04-21T00:00:00-04:00",
    "actual_end_date": "2025-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-11-13T18:50:54-05:00",
    "status": "resolved",
    "en_comments": "Resupply date is  Nov 30/25",
    "en_drug_brand_name": "TEVA-LENOLTEC NO. 4",
    "en_drug_common_name": "LENOLTEC NO. 4",
    "fr_drug_brand_name": "TEVA-LENOLTEC NO. 4",
    "fr_drug_common_name": "LENOLTEC NO. 4",
    "en_ingredients": "CODEINE PHOSPHATE\r\nACETAMINOPHEN",
    "fr_ingredients": "Phosphate de codéine\r\nAcétaminophène",
    "drug_strength": "60MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255675,
    "drug": {
      "current_status": "MARKETED",
      "id": 10572,
      "drug_code": 6611,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250918,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00648035",
      "brand_name": "TEVA-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "FILM COATED",
      "pediatric_flag": false,
      "accession_number": "63648",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2025-04-24T19:20:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00648035",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2025-10-10T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-10T16:36:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-METOPROLOL",
    "en_drug_common_name": "METOPROLOL 50MG FC TABLETS",
    "fr_drug_brand_name": "TEVA-METOPROLOL 50MG FC TABLETS",
    "fr_drug_common_name": "METOPROLOL 50MG FC TABLETS",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255678,
    "drug": {
      "current_status": "MARKETED",
      "id": 32166,
      "drug_code": 9886,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251236,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00842648",
      "brand_name": "TEVA-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "UNCOATED",
      "pediatric_flag": false,
      "accession_number": "69242",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2025-04-24T19:21:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00842648",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2025-10-20T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-29T13:11:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-METOPROLOL",
    "en_drug_common_name": "METOPROLOL 50MG UNCOAT TABS",
    "fr_drug_brand_name": "TEVA-METOPROLOL 50MG UNCOAT TABS",
    "fr_drug_common_name": "METOPROLOL 50MG UNCOAT TABS",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255681,
    "drug": {
      "current_status": "MARKETED",
      "id": 2098,
      "drug_code": 14445,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251963,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00849650",
      "brand_name": "TEVA-TOPILENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76063",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2025-04-24T19:22:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00849650",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2025-06-10T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-30T18:33:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOPILENE",
    "en_drug_common_name": "TOPILENE 0.05% CREAM",
    "fr_drug_brand_name": "TEVA-TOPILENE 0.05% CREAM",
    "fr_drug_common_name": "TOPILENE 0.05% CREAM",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone (Dipropionate de bétaméthasone)",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255684,
    "drug": {
      "current_status": "MARKETED",
      "id": 1772,
      "drug_code": 13848,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251815,
          "ingredient": {
            "id": 40,
            "ingredient_code": 2037,
            "en_name": "NAPROXEN SODIUM",
            "fr_name": "Naproxène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "550",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02026600",
      "brand_name": "TEVA-NAPROXEN SODIUM DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75311",
      "number_of_ais": "1",
      "ai_group_no": "0113934002"
    },
    "created_date": "2025-04-24T19:23:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02026600",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2025-08-31T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-21T15:43:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN SODIUM DS",
    "en_drug_common_name": "NAPROXEN SODIUM DS 550MG TABS",
    "fr_drug_brand_name": "TEVA-NAPROXEN SODIUM DS 550MG TABS",
    "fr_drug_common_name": "NAPROXEN SODIUM DS 550MG TABS",
    "en_ingredients": "NAPROXEN SODIUM",
    "fr_ingredients": "Naproxène sodique",
    "drug_strength": "550MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255687,
    "drug": {
      "current_status": "MARKETED",
      "id": 10668,
      "drug_code": 66289,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254043,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242538",
      "brand_name": "TEVA-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863004"
    },
    "created_date": "2025-04-24T19:25:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242538",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2025-07-31T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-08T18:51:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD 120MG CAPS",
    "fr_drug_brand_name": "TEVA-DILTIAZEM CD 120MG CAPS",
    "fr_drug_common_name": "DILTIAZEM CD 120MG CAPS",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)\r\nCAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)\r\nCapsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255690,
    "drug": {
      "current_status": "MARKETED",
      "id": 10670,
      "drug_code": 66290,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254044,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242539",
      "brand_name": "TEVA-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2025-04-24T19:26:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242539",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2025-07-31T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-08T18:52:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD 180MG CAP",
    "fr_drug_brand_name": "TEVA-DILTIAZEM CD 180MG CAP",
    "fr_drug_common_name": "DILTIAZEM CD 180MG CAP",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)\r\nCAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)\r\nCapsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255693,
    "drug": {
      "current_status": "MARKETED",
      "id": 10672,
      "drug_code": 66291,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254045,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242540",
      "brand_name": "TEVA-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863006"
    },
    "created_date": "2025-04-24T19:27:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242540",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2025-07-31T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-08T18:50:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD 240MG CAPSULES",
    "fr_drug_brand_name": "TEVA-DILTIAZEM CD 240MG CAPSULES",
    "fr_drug_common_name": "DILTIAZEM CD 240MG CAPSULES",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "240MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)\r\nCAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)\r\nCapsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255698,
    "drug": {
      "current_status": "MARKETED",
      "id": 13252,
      "drug_code": 72809,
      "updated_date": "2025-05-15T02:31:29-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254808,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248457",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "600MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929004"
    },
    "created_date": "2025-04-24T19:47:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248457",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02BF",
    "estimated_end_date": "2025-10-20T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-16T14:26:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 600MG TAB",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 600MG TAB",
    "fr_drug_common_name": "GABAPENTIN 600MG TAB",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255706,
    "drug": {
      "current_status": "MARKETED",
      "id": 16276,
      "drug_code": 77064,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255809,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285134",
      "brand_name": "TEVA-LISINOPRIL (TYPE Z)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2025-04-24T19:50:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285134",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2025-05-31T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-30T18:33:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LISINOPRIL (TYPE Z)",
    "en_drug_common_name": "LISINOPRIL Z 20MG TAB",
    "fr_drug_brand_name": "TEVA-LISINOPRIL Z 20MG TAB",
    "fr_drug_common_name": "LISINOPRIL Z 20MG TAB",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255709,
    "drug": {
      "current_status": "MARKETED",
      "id": 18964,
      "drug_code": 80234,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256632,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316846",
      "brand_name": "TEVA-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618001"
    },
    "created_date": "2025-04-24T19:51:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316846",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2025-11-10T00:00:00-05:00",
    "actual_start_date": "2025-04-23T00:00:00-04:00",
    "actual_end_date": "2025-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-11-13T18:45:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE 0.25MG FC TAB",
    "fr_drug_brand_name": "TEVA-ROPINIROLE 0.25MG FC TAB",
    "fr_drug_common_name": "ROPINIROLE 0.25MG FC TAB",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "Ropinirole (Chlorhydrate de ropinirole)",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255714,
    "drug": {
      "current_status": "MARKETED",
      "id": 28730,
      "drug_code": 90861,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260425,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423863",
      "brand_name": "TEVA-ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2025-04-24T19:53:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423863",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2025-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-11-20T14:51:14-05:00",
    "status": "active_confirmed",
    "en_comments": "Suspended Supply",
    "en_drug_brand_name": "TEVA-ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE 40MG OG TAB",
    "fr_drug_brand_name": "TEVA-ESOMEPRAZOLE 40MG OG TAB",
    "fr_drug_common_name": "ESOMEPRAZOLE 40MG OG TAB",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "Ésoméprazole (Ésoméprazole magnésien dihydraté)",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255716,
    "drug": {
      "current_status": "MARKETED",
      "id": 62328,
      "drug_code": 93082,
      "updated_date": "2025-12-03T00:32:55-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261430,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445549",
      "brand_name": "APO-AMPHETAMINE XR",
      "brand_name_fr": "APO-AMPHÉTAMINE XR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310006"
    },
    "created_date": "2025-04-24T19:53:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445549",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-07-25T00:00:00-04:00",
    "actual_start_date": "2025-04-22T00:00:00-04:00",
    "actual_end_date": "2025-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-25T17:27:37-04:00",
    "status": "resolved",
    "en_comments": "limited inventory available",
    "fr_comments": "limited inventory available",
    "en_drug_brand_name": "APO-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR",
    "fr_drug_brand_name": "APO-AMPHETAMINE XR",
    "fr_drug_common_name": "AMPHETAMINE XR",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "Sels mixtes d'amphétamine",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255740,
    "drug": {
      "current_status": "MARKETED",
      "id": 7662,
      "drug_code": 50552,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253370,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231245",
      "brand_name": "PMS-IPRATROPIUM",
      "brand_name_fr": "",
      "descriptor": "2ML UNIT DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2025-04-25T14:40:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231245",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2025-04-24T00:00:00-04:00",
    "actual_end_date": "2025-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-02T13:37:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IPRATROPIUM",
    "en_drug_common_name": "IPRATROPIUM",
    "fr_drug_brand_name": "PMS-IPRATROPIUM",
    "fr_drug_common_name": "IPRATROPIUM",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "10x2ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 255743,
    "drug": {
      "current_status": "MARKETED",
      "id": 4052,
      "drug_code": 19763,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252570,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02208229",
      "brand_name": "PMS-SALBUTAMOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82059",
      "number_of_ais": "1",
      "ai_group_no": "0108887007"
    },
    "created_date": "2025-04-25T14:51:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02208229",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2025-05-21T00:00:00-04:00",
    "actual_start_date": "2025-04-24T00:00:00-04:00",
    "actual_end_date": "2025-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-21T20:19:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SALBUTAMOL",
    "en_drug_common_name": "SALBUTAMOL",
    "fr_drug_brand_name": "pms-SALBUTAMOL",
    "fr_drug_common_name": "SALBUTAMOL",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol (Sulfate de salbutamol)",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20x2.5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255746,
    "drug": {
      "current_status": "MARKETED",
      "id": 11162,
      "drug_code": 67440,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254193,
          "ingredient": {
            "id": 2374,
            "ingredient_code": 11368,
            "en_name": "TERAZOSIN",
            "fr_name": "Térazosine (Chlorhydrate de térazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243521",
      "brand_name": "PMS-TERAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136978004"
    },
    "created_date": "2025-04-25T14:53:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243521",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-24T00:00:00-04:00",
    "actual_end_date": "2025-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-23T17:17:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-TERAZOSIN",
    "en_drug_common_name": "TERAZOSIN",
    "fr_drug_brand_name": "pms-TERAZOSIN",
    "fr_drug_common_name": "TERAZOSIN",
    "en_ingredients": "TERAZOSIN",
    "fr_ingredients": "Térazosine (Chlorhydrate de térazosine)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255771,
    "drug": {
      "current_status": "MARKETED",
      "id": 104054,
      "drug_code": 102510,
      "updated_date": "2023-08-11T12:29:20-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8267971,
          "ingredient": {
            "id": 310,
            "ingredient_code": 7486,
            "en_name": "TESTOSTERONE ENANTHATE",
            "fr_name": "Énanthate de testosterone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02536315",
      "brand_name": "TESTOSTERONE ENANTHATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106403001"
    },
    "created_date": "2025-04-25T15:25:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02536315",
    "company_name": "HIKMA CANADA LIMITED",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "estimated_end_date": "2025-09-30T00:00:00-04:00",
    "actual_start_date": "2025-04-25T00:00:00-04:00",
    "actual_end_date": "2025-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-10-08T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Inventory available on allocation at distributors.",
    "fr_comments": "Inventaire disponible en allocation chez les distributeurs.",
    "en_drug_brand_name": "TESTOSTERONE ENANTHATE INJECTION, USP",
    "en_drug_common_name": "TESTOSTERONE ENANTHATE INJECTION, USP",
    "fr_drug_brand_name": "TESTOSTERONE ENANTHATE INJECTION, USP",
    "fr_drug_common_name": "TESTOSTERONE ENANTHATE INJECTION, USP",
    "en_ingredients": "TESTOSTERONE ENANTHATE",
    "fr_ingredients": "Énanthate de testosterone",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255774,
    "drug": {
      "current_status": "MARKETED",
      "id": 103453,
      "drug_code": 102138,
      "updated_date": "2022-12-08T06:17:06-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8267595,
          "ingredient": {
            "id": 3378,
            "ingredient_code": 20128,
            "en_name": "MICAFUNGIN SODIUM",
            "fr_name": "Micafungine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02532344",
      "brand_name": "MICAFUNGIN SODIUM FOR INJECTION",
      "brand_name_fr": "MICAFUNGINE SODIQUE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152203002"
    },
    "created_date": "2025-04-25T15:27:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02532344",
    "company_name": "HIKMA CANADA LIMITED",
    "atc_number": "J02AX",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "actual_start_date": "2025-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-26T05:00:17-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MICAFUNGIN SODIUM FOR INJECTION",
    "en_drug_common_name": "MICAFUNGIN SODIUM FOR INJECTION",
    "fr_drug_brand_name": "MICAFUNGIN SODIUM FOR INJECTION",
    "fr_drug_common_name": "MICAFUNGIN SODIUM FOR INJECTION",
    "en_ingredients": "MICAFUNGIN SODIUM",
    "fr_ingredients": "Micafungine sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "50mg",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255777,
    "drug": {
      "current_status": "MARKETED",
      "id": 11186,
      "drug_code": 67514,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254203,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243596",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732004"
    },
    "created_date": "2025-04-25T15:41:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243596",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2025-07-11T00:00:00-04:00",
    "estimated_end_date": "2025-08-15T00:00:00-04:00",
    "actual_start_date": "2025-07-09T00:00:00-04:00",
    "actual_end_date": "2025-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-08-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "400MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255782,
    "drug": {
      "current_status": "MARKETED",
      "id": 21250,
      "drug_code": 83640,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8257529,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351218",
      "brand_name": "ACH-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2025-04-25T17:53:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351218",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "actual_start_date": "2025-04-24T00:00:00-04:00",
    "actual_end_date": "2025-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-12-30T06:00:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ANASTROZOLE",
    "en_drug_common_name": "ANASTROZOLE",
    "fr_drug_brand_name": "ACH Anastrozole",
    "fr_drug_common_name": "Anastrozole",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255812,
    "drug": {
      "current_status": "MARKETED",
      "id": 32172,
      "drug_code": 9889,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251238,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00808547",
      "brand_name": "TEVA-DICLOFENAC EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69245",
      "number_of_ais": "1",
      "ai_group_no": "0114417002"
    },
    "created_date": "2025-04-25T19:28:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00808547",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:28:17-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-DICLOFENAC EC",
    "en_drug_common_name": "DICLOFENAC 50MG",
    "fr_drug_brand_name": "TEVA-DICLOFENAC 50MG",
    "fr_drug_common_name": "DICLOFENAC 50MG",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's and 500's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255815,
    "drug": {
      "current_status": "MARKETED",
      "id": 1596,
      "drug_code": 13438,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251766,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01910299",
      "brand_name": "TEVA-CLOBETASOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74825",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2025-04-25T19:29:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01910299",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:29:56-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-CLOBETASOL",
    "en_drug_common_name": "TEVA-CLOBETASOL",
    "fr_drug_brand_name": "TEVA-CLOBETASOL",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "20 & 60ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255818,
    "drug": {
      "current_status": "MARKETED",
      "id": 4006,
      "drug_code": 19681,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252552,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02099705",
      "brand_name": "METHOTREXATE SODIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81977",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2025-04-25T19:31:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02099705",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:31:25-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "METHOTREXATE SODIUM INJECTION",
    "en_drug_common_name": "METHOTREXATE SODIUM INJECTION",
    "fr_drug_brand_name": "METHOTREXATE SODIUM INJECTION",
    "fr_drug_common_name": "METHOTREXATE SODIUM INJECTION",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate (Méthotrexate sodique)",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL\r\nINTRACEREBROVENTRICULAR\r\nINTRACEREBROVENTRICULAR\r\nINTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle\r\nIntracérébroventriculaire\r\nIntracérébroventriculaire\r\nIntraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle",
    "drug_package_quantity": "2 & 20ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255821,
    "drug": {
      "current_status": "MARKETED",
      "id": 14920,
      "drug_code": 75325,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255342,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02267845",
      "brand_name": "TEVA-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2025-04-25T19:33:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02267845",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:33:48-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "TEVA-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 & PP 6",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255824,
    "drug": {
      "current_status": "MARKETED",
      "id": 15868,
      "drug_code": 76618,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255682,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280523",
      "brand_name": "TEVA-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2025-04-25T19:34:51-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02280523",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:35:02-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "TEVA-LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's and 500's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255827,
    "drug": {
      "current_status": "MARKETED",
      "id": 21832,
      "drug_code": 84210,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257801,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257800,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356996",
      "brand_name": "TEVA-VALSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240204001"
    },
    "created_date": "2025-04-25T19:36:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02356996",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:36:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "en_drug_common_name": "VALSARTAN/HCTZ",
    "fr_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "fr_drug_common_name": "VALSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nVALSARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nValsartan",
    "drug_strength": "12.5MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50 & PP30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255830,
    "drug": {
      "current_status": "MARKETED",
      "id": 21834,
      "drug_code": 84211,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257803,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257802,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357003",
      "brand_name": "TEVA-VALSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240204002"
    },
    "created_date": "2025-04-25T19:37:54-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02357003",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:38:11-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "en_drug_common_name": "VALSARTAN/HCTZ",
    "fr_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "fr_drug_common_name": "VALSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nVALSARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nValsartan",
    "drug_strength": "12.5MG\r\n160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50 & PP30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255833,
    "drug": {
      "current_status": "MARKETED",
      "id": 21836,
      "drug_code": 84212,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257805,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257804,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357011",
      "brand_name": "TEVA-VALSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240204003"
    },
    "created_date": "2025-04-25T19:38:59-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02357011",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:39:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "en_drug_common_name": "VALSARTAN/HCTZ",
    "fr_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "fr_drug_common_name": "VALSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nVALSARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nValsartan",
    "drug_strength": "25MG\r\n160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50 & PP30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255840,
    "drug": {
      "current_status": "MARKETED",
      "id": 5684,
      "drug_code": 37454,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252913,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252912,
          "ingredient": {
            "id": 2018,
            "ingredient_code": 9068,
            "en_name": "ESCULIN",
            "fr_name": "Esculine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252911,
          "ingredient": {
            "id": 2016,
            "ingredient_code": 7053,
            "en_name": "DIBUCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dibucaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252910,
          "ingredient": {
            "id": 1292,
            "ingredient_code": 8626,
            "en_name": "FRAMYCETIN SULFATE",
            "fr_name": "Sulfate de framycétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02226383",
      "brand_name": "TEVA-PROCTOSONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4990",
      "number_of_ais": "4",
      "ai_group_no": "0404592001"
    },
    "created_date": "2025-04-25T19:43:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02226383",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C05AA",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-25T19:43:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-PROCTOSONE",
    "en_drug_common_name": "PROCTOSONE",
    "fr_drug_brand_name": "TEVA-PROCTOSONE",
    "fr_drug_common_name": "PROCTOSONE",
    "en_ingredients": "ESCULIN\r\nFRAMYCETIN SULFATE\r\nDIBUCAINE HYDROCHLORIDE\r\nHYDROCORTISONE",
    "fr_ingredients": "Esculine\r\nSulfate de framycétine\r\nChlorhydrate de dibucaïne\r\nHydrocortisone",
    "drug_strength": "1%\r\n1%\r\n0.5%\r\n0.5%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "15 & 30g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255855,
    "drug": {
      "current_status": "MARKETED",
      "id": 7294,
      "drug_code": 49290,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253268,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230420",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238005"
    },
    "created_date": "2025-04-25T23:36:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230420",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2025-05-01T00:00:00-04:00",
    "estimated_end_date": "2025-06-24T00:00:00-04:00",
    "actual_start_date": "2025-05-01T00:00:00-04:00",
    "actual_end_date": "2025-06-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-25T20:16:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan (Succinate de sumatriptan)",
    "drug_strength": "20MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "2's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255858,
    "drug": {
      "current_status": "MARKETED",
      "id": 7292,
      "drug_code": 49288,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253267,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230418",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238003"
    },
    "created_date": "2025-04-25T23:43:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230418",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2025-05-16T00:00:00-04:00",
    "estimated_end_date": "2025-07-15T00:00:00-04:00",
    "actual_start_date": "2025-05-16T00:00:00-04:00",
    "actual_end_date": "2025-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-12T01:06:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan (Succinate de sumatriptan)",
    "drug_strength": "5MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "2's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255885,
    "drug": {
      "current_status": "MARKETED",
      "id": 31912,
      "drug_code": 94437,
      "updated_date": "2025-12-03T00:33:11-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262103,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457318",
      "brand_name": "SANDOZ AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310003"
    },
    "created_date": "2025-04-28T13:28:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457318",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-06-20T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-06-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-02T13:31:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR",
    "fr_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "fr_drug_common_name": "AMPHETAMINE XR",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "Sels mixtes d'amphétamine",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRCH",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255888,
    "drug": {
      "current_status": "MARKETED",
      "id": 31918,
      "drug_code": 94440,
      "updated_date": "2025-12-03T00:33:11-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262106,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457342",
      "brand_name": "SANDOZ AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "30MG MIXED SALTS AMPHETAMINE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310006"
    },
    "created_date": "2025-04-28T13:30:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457342",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2025-05-02T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-15T14:44:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR",
    "fr_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "fr_drug_common_name": "AMPHETAMINE XR",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "Sels mixtes d'amphétamine",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRCH",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255891,
    "drug": {
      "current_status": "MARKETED",
      "id": 19910,
      "drug_code": 81230,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256959,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326973",
      "brand_name": "SANDOZ CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2025-04-28T13:32:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326973",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2025-05-30T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-27T05:00:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "SANDOZ CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255894,
    "drug": {
      "current_status": "MARKETED",
      "id": 101134,
      "drug_code": 99623,
      "updated_date": "2020-11-09T00:55:07-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8265718,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        },
        {
          "id": 8265717,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02506882",
      "brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250083001"
    },
    "created_date": "2025-04-28T13:34:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02506882",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S02CA",
    "atc_description": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
    "estimated_end_date": "2025-05-09T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-13T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
    "en_drug_common_name": "CIPROFLOXACIN / DEXAMETHASONE",
    "fr_drug_brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
    "fr_drug_common_name": "CIPROFLOXACIN / DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE\r\nCIPROFLOXACIN",
    "fr_ingredients": "Dexaméthasone\r\nCiprofloxacine (Chlorhydrate de ciprofloxacine)",
    "drug_strength": "0.1%\r\n0.3%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OTIC",
    "drug_route_fr": "Otique",
    "drug_package_quantity": "7.5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255897,
    "drug": {
      "current_status": "MARKETED",
      "id": 20060,
      "drug_code": 81401,
      "updated_date": "2025-05-15T02:32:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257060,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328496",
      "brand_name": "SANDOZ IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2025-04-28T13:36:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328496",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2025-05-16T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-13T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255900,
    "drug": {
      "current_status": "MARKETED",
      "id": 17348,
      "drug_code": 78395,
      "updated_date": "2025-12-03T00:31:14-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256114,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298635",
      "brand_name": "SANDOZ LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663003"
    },
    "created_date": "2025-04-28T13:38:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298635",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2025-07-25T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-22T05:00:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine (Hémihydrate de lévofloxacine)",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255903,
    "drug": {
      "current_status": "MARKETED",
      "id": 102859,
      "drug_code": 101032,
      "updated_date": "2022-05-08T04:00:40-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8266645,
          "ingredient": {
            "id": 3800,
            "ingredient_code": 21372,
            "en_name": "LURASIDONE HYDROCHLORIDE",
            "fr_name": "chlorhydrate de lurasidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02521091",
      "brand_name": "SANDOZ LURASIDONE",
      "brand_name_fr": "",
      "descriptor": "LURASIDONE HYDROCHLORIDE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153185001"
    },
    "created_date": "2025-04-28T13:40:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02521091",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AE",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-05-23T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-20T13:11:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LURASIDONE",
    "en_drug_common_name": "LURASIDONE",
    "fr_drug_brand_name": "SANDOZ LURASIDONE",
    "fr_drug_common_name": "LURASIDONE",
    "en_ingredients": "LURASIDONE HYDROCHLORIDE",
    "fr_ingredients": "chlorhydrate de lurasidone",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255907,
    "drug": {
      "current_status": "MARKETED",
      "id": 27540,
      "drug_code": 89783,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259953,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413159",
      "brand_name": "SANDOZ TOLTERODINE LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202003"
    },
    "created_date": "2025-04-28T13:41:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413159",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-12T13:17:45-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "SANDOZ TOLTERODINE LA",
    "en_drug_common_name": "TOLTERODINE LA",
    "fr_drug_brand_name": "SANDOZ TOLTERODINE LA",
    "fr_drug_common_name": "TOLTERODINE LA",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRCH",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255911,
    "drug": {
      "current_status": "MARKETED",
      "id": 57522,
      "drug_code": 81111,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256902,
          "ingredient": {
            "id": 2414,
            "ingredient_code": 11443,
            "en_name": "TRANDOLAPRIL",
            "fr_name": "Trandolapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325756",
      "brand_name": "SANDOZ TRANDOLAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131524003"
    },
    "created_date": "2025-04-28T13:43:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325756",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2025-05-09T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-13T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TRANDOLAPRIL",
    "en_drug_common_name": "TRANDOLAPRIL",
    "fr_drug_brand_name": "SANDOZ TRANDOLAPRIL",
    "fr_drug_common_name": "TRANDOLAPRIL",
    "en_ingredients": "TRANDOLAPRIL",
    "fr_ingredients": "Trandolapril",
    "drug_strength": "2MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100HGC",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255932,
    "drug": {
      "current_status": "MARKETED",
      "id": 4674,
      "drug_code": 2423,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250409,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8250408,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8250407,
          "ingredient": {
            "id": 106,
            "ingredient_code": 8519,
            "en_name": "POLYMYXIN B SULFATE",
            "fr_name": "Sulfate de polymyxine b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00358177",
      "brand_name": "MAXITROL",
      "brand_name_fr": "",
      "descriptor": "OINTMENT",
      "pediatric_flag": false,
      "accession_number": "49526",
      "number_of_ais": "3",
      "ai_group_no": "0305643001"
    },
    "created_date": "2025-04-28T14:32:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00358177",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01CA",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "anticipated_start_date": "2025-04-28T00:00:00-04:00",
    "estimated_end_date": "2025-08-18T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-19T13:31:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXITROL",
    "en_drug_common_name": "MAXITROL OINTMENT 3.5G",
    "fr_drug_brand_name": "MAXITROL",
    "fr_drug_common_name": "MAXITROL OINTMENT 3.5G",
    "en_ingredients": "POLYMYXIN B SULFATE\r\nNEOMYCIN\r\nDEXAMETHASONE",
    "fr_ingredients": "Sulfate de polymyxine b\r\nNéomycine (Sulfate de néomycine)\r\nDexaméthasone",
    "drug_strength": "6000UNIT\r\n3.5MG\r\n0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "3.5G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255935,
    "drug": {
      "current_status": "MARKETED",
      "id": 446,
      "drug_code": 10971,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251456,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8251455,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00778915",
      "brand_name": "TOBRADEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71136",
      "number_of_ais": "2",
      "ai_group_no": "0220325001"
    },
    "created_date": "2025-04-28T14:34:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00778915",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01CA",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "anticipated_start_date": "2025-04-28T00:00:00-04:00",
    "estimated_end_date": "2025-08-18T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-19T13:29:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBRADEX",
    "en_drug_common_name": "TOBRADEX OINTMENT 3.5G",
    "fr_drug_brand_name": "TOBRADEX",
    "fr_drug_common_name": "TOBRADEX OINTMENT 3.5G",
    "en_ingredients": "DEXAMETHASONE\r\nTOBRAMYCIN",
    "fr_ingredients": "Dexaméthasone\r\nTobramycine (Sulfate de tobramycine)",
    "drug_strength": "0.1%\r\n0.3%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "3.5G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 255940,
    "drug": {
      "current_status": "MARKETED",
      "id": 6872,
      "drug_code": 4591,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250651,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00042579",
      "brand_name": "MAXIDEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58173",
      "number_of_ais": "1",
      "ai_group_no": "0106303004"
    },
    "created_date": "2025-04-28T14:38:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00042579",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2025-06-01T00:00:00-04:00",
    "estimated_end_date": "2025-08-18T00:00:00-04:00",
    "actual_start_date": "2025-06-11T00:00:00-04:00",
    "actual_end_date": "2025-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-19T13:29:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXIDEX",
    "en_drug_common_name": "MAXIDEX OINTMENT 3.5G",
    "fr_drug_brand_name": "MAXIDEX",
    "fr_drug_common_name": "MAXIDEX OINTMENT 3.5G",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "3.5G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256008,
    "drug": {
      "current_status": "MARKETED",
      "id": 64918,
      "drug_code": 97378,
      "updated_date": "2025-05-15T02:37:04-04:00",
      "company": {
        "id": 7815,
        "created_date": "2018-05-03T02:30:12-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 17067,
        "mfr_code": "",
        "name": "AVIR PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263747,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02483343",
      "brand_name": "ACETAMINOPHEN INJECTION",
      "brand_name_fr": "ACÉTAMINOPHÈNE INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009015"
    },
    "created_date": "2025-04-28T20:03:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02483343",
    "company_name": "AVIR PHARMA INC.",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "anticipated_start_date": "2025-04-28T00:00:00-04:00",
    "estimated_end_date": "2025-10-30T00:00:00-04:00",
    "actual_start_date": "2025-04-28T00:00:00-04:00",
    "actual_end_date": "2025-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-10-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAMINOPHEN INJECTION",
    "en_drug_common_name": "Aceta. Injection, 10mg/ml, 12 Bags of 100mL",
    "fr_drug_brand_name": "Acetaminophen injection",
    "fr_drug_common_name": "Acéta. Injection, 10mg/ml, 12 Sacs de 100mL",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256013,
    "drug": {
      "current_status": "MARKETED",
      "id": 19254,
      "drug_code": 80510,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8256734,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256733,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02319632",
      "brand_name": "OLMETEC PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502003"
    },
    "created_date": "2025-04-28T20:23:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319632",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2025-05-09T00:00:00-04:00",
    "estimated_end_date": "2025-09-19T00:00:00-04:00",
    "actual_start_date": "2025-04-30T00:00:00-04:00",
    "actual_end_date": "2025-09-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-09-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OLMETEC PLUS",
    "en_drug_common_name": "Olmesartan medoxomil and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "OLMETEC PLUS",
    "fr_drug_common_name": "comprimés d'olmésartan médoxomil et hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nOlmésartan médoxomil",
    "drug_strength": "25MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256018,
    "drug": {
      "current_status": "MARKETED",
      "id": 6946,
      "drug_code": 47216,
      "updated_date": "2025-12-03T00:30:38-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253205,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02229411",
      "brand_name": "NAROPIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273001"
    },
    "created_date": "2025-04-28T21:05:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229411",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2025-04-21T00:00:00-04:00",
    "actual_end_date": "2025-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-22T17:51:11-04:00",
    "status": "resolved",
    "en_comments": "VR89891CA1 NAROPIN 2MG/ML LIQ POLYBAG 5X200ML CA AS",
    "fr_comments": "VR89891CA1\tNAROPIN 2MG/ML LIQ POLYBAG 5X200ML CA AS",
    "en_drug_brand_name": "NAROPIN",
    "en_drug_common_name": "ropivacaine HCl 2mg/mL 5x200mL SU Polybag®",
    "fr_drug_brand_name": "NAROPIN",
    "fr_drug_common_name": "ropivacaine HCl 2mg/mL 5x200mL SU Polybag®",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nBLOCK/INFILTRATION\r\nBLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nBloc/Infiltration\r\nBloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "5 PP Polybag",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256076,
    "drug": {
      "current_status": "MARKETED",
      "id": 10284,
      "drug_code": 6529,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250914,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00629367",
      "brand_name": "DIPROLENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63349",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2025-04-29T17:05:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00629367",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2025-09-05T00:00:00-04:00",
    "estimated_end_date": "2026-01-23T00:00:00-05:00",
    "actual_start_date": "2025-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-07-16T20:30:42-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "DIPROLENE",
    "en_drug_common_name": "BETAMETHASONE DIPROPIONATE CREAM (glycol)",
    "fr_drug_brand_name": "DIPROLENE POMMADE",
    "fr_drug_common_name": "CRÈME DE DIPROPIONATE DE BÉTAMÉTHASONE (avec propylene glycol)",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone (Dipropionate de bétaméthasone)",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256079,
    "drug": {
      "current_status": "MARKETED",
      "id": 17320,
      "drug_code": 78368,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256099,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298384",
      "brand_name": "TEVA-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301001"
    },
    "created_date": "2025-04-29T17:35:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02298384",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:35:53-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE 30MG",
    "fr_drug_brand_name": "TEVA-RISEDRONATE 30MG",
    "fr_drug_common_name": "RISEDRONATE 30MG",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique (Hémipentahydrate de risédronate sodique)",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256082,
    "drug": {
      "current_status": "MARKETED",
      "id": 31072,
      "drug_code": 93234,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261486,
          "ingredient": {
            "id": 848,
            "ingredient_code": 7554,
            "en_name": "PROGESTERONE",
            "fr_name": "Progestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02446820",
      "brand_name": "ACT PROGESTERONE INJECTION",
      "brand_name_fr": "ACT INJECTION DE PROGESTERONE",
      "descriptor": "MULTI DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106327001"
    },
    "created_date": "2025-04-29T17:37:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02446820",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:37:17-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ACT PROGESTERONE INJECTION",
    "en_drug_common_name": "PROGESTERONE INJECTION 500MG/10ML",
    "fr_drug_brand_name": "ACT PROGESTERONE INJECTION 500MG/10ML",
    "fr_drug_common_name": "PROGESTERONE INJECTION 500MG/10ML",
    "en_ingredients": "PROGESTERONE",
    "fr_ingredients": "Progestérone",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256085,
    "drug": {
      "current_status": "MARKETED",
      "id": 15866,
      "drug_code": 76617,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255681,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280515",
      "brand_name": "TEVA-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2025-04-29T17:38:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02280515",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:38:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE 15MG",
    "fr_drug_brand_name": "TEVA-LANSOPRAZOLE 15MG",
    "fr_drug_common_name": "LANSOPRAZOLE 15MG",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256088,
    "drug": {
      "current_status": "MARKETED",
      "id": 51689,
      "drug_code": 88865,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259589,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403889",
      "brand_name": "TEVA-TENOFOVIR",
      "brand_name_fr": "",
      "descriptor": "EQUIVALENT TO 245 MG TENOFOVIR DISOPROXIL.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152569001"
    },
    "created_date": "2025-04-29T17:44:27-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02403889",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:44:48-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-TENOFOVIR",
    "en_drug_common_name": "TENOFOVIR 300MG",
    "fr_drug_brand_name": "TEVA-TENOFOVIR 300MG",
    "fr_drug_common_name": "TENOFOVIR 300MG",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256091,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8624,
      "drug_code": 60274,
      "updated_date": "2025-12-03T01:16:52-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8324432,
          "ingredient": {
            "id": 286,
            "ingredient_code": 1204,
            "en_name": "FLUCONAZOLE",
            "fr_name": "Fluconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236979",
      "brand_name": "TEVA-FLUCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122529002"
    },
    "created_date": "2025-04-29T17:45:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02236979",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:45:58-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-FLUCONAZOLE",
    "en_drug_common_name": "FLUCONAZOLE 100MG",
    "fr_drug_brand_name": "TEVA-FLUCONAZOLE 100MG",
    "fr_drug_common_name": "FLUCONAZOLE 100MG",
    "en_ingredients": "FLUCONAZOLE",
    "fr_ingredients": "Fluconazole",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256094,
    "drug": {
      "id": 28682,
      "drug_code": 90813,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260407,
          "ingredient": {
            "id": 3194,
            "ingredient_code": 13053,
            "en_name": "BORTEZOMIB",
            "fr_name": "Bortézomib (Bortézomib, ester boronique de mannitol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02423405",
      "brand_name": "BORTEZOMIB FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150433001"
    },
    "created_date": "2025-04-29T17:47:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02423405",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01XG",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:47:16-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BORTEZOMIB FOR INJECTION",
    "en_drug_common_name": "BORTEZOMIB FOR INJECTION 3.5MG",
    "fr_drug_brand_name": "BORTEZOMIB FOR INJECTION 3.5MG",
    "fr_drug_common_name": "BORTEZOMIB FOR INJECTION 3.5MG",
    "en_ingredients": "BORTEZOMIB",
    "fr_ingredients": "Bortézomib (Bortézomib, ester boronique de mannitol)",
    "drug_strength": "3.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256104,
    "drug": {
      "current_status": "MARKETED",
      "id": 30518,
      "drug_code": 92544,
      "updated_date": "2025-05-15T02:34:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261193,
          "ingredient": {
            "id": 2406,
            "ingredient_code": 11431,
            "en_name": "TOPOTECAN",
            "fr_name": "Topotécane (Chlorhydrate de topotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02441071",
      "brand_name": "TEVA-TOPOTECAN",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132984001"
    },
    "created_date": "2025-04-29T17:50:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02441071",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01CE",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:50:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-TOPOTECAN",
    "en_drug_common_name": "TOPOTECAN 4MG",
    "fr_drug_brand_name": "TEVA-TOPOTECAN 4MG",
    "fr_drug_common_name": "TOPOTECAN 4MG",
    "en_ingredients": "TOPOTECAN",
    "fr_ingredients": "Topotécane (Chlorhydrate de topotécan)",
    "drug_strength": "4MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256113,
    "drug": {
      "current_status": "MARKETED",
      "id": 6380,
      "drug_code": 43299,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253054,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02221284",
      "brand_name": "TEVA-MEDROXYPROGESTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9630",
      "number_of_ais": "1",
      "ai_group_no": "0106339004"
    },
    "created_date": "2025-04-29T17:51:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02221284",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:52:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-MEDROXYPROGESTERONE",
    "en_drug_common_name": "MEDROXYPROGESTERONE 2.5MG",
    "fr_drug_brand_name": "TEVA-MEDROXYPROGESTERONE 2.5MG",
    "fr_drug_common_name": "MEDROXYPROGESTERONE 2.5MG",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256116,
    "drug": {
      "current_status": "MARKETED",
      "id": 6384,
      "drug_code": 43300,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253055,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02221292",
      "brand_name": "TEVA-MEDROXYPROGESTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9631",
      "number_of_ais": "1",
      "ai_group_no": "0106339005"
    },
    "created_date": "2025-04-29T17:53:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02221292",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:53:42-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-MEDROXYPROGESTERONE",
    "en_drug_common_name": "MEDROXYPROGESTERONE 5MG",
    "fr_drug_brand_name": "TEVA-MEDROXYPROGESTERONE 5MG",
    "fr_drug_common_name": "MEDROXYPROGESTERONE 5MG",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256119,
    "drug": {
      "current_status": "MARKETED",
      "id": 6386,
      "drug_code": 43301,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253056,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02221306",
      "brand_name": "TEVA-MEDROXYPROGESTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9632",
      "number_of_ais": "1",
      "ai_group_no": "0106339006"
    },
    "created_date": "2025-04-29T17:54:35-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02221306",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T17:54:55-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-MEDROXYPROGESTERONE",
    "en_drug_common_name": "MEDROXYPROGESTERONE 10MG",
    "fr_drug_brand_name": "TEVA-MEDROXYPROGESTERONE 10MG",
    "fr_drug_common_name": "MEDROXYPROGESTERONE 10MG",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256122,
    "drug": {
      "current_status": "MARKETED",
      "id": 16362,
      "drug_code": 77144,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255829,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285959",
      "brand_name": "TEVA-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506002"
    },
    "created_date": "2025-04-29T18:10:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02285959",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:11:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR 200MG",
    "fr_drug_brand_name": "TEVA-ACYCLOVIR 200MG",
    "fr_drug_common_name": "ACYCLOVIR 200MG",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir (Acyclovir sodique)",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256125,
    "drug": {
      "current_status": "MARKETED",
      "id": 16364,
      "drug_code": 77145,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255830,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285967",
      "brand_name": "TEVA-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2025-04-29T18:12:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02285967",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:12:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR 400MG",
    "fr_drug_brand_name": "TEVA-ACYCLOVIR 400MG",
    "fr_drug_common_name": "ACYCLOVIR 400MG",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir (Acyclovir sodique)",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256128,
    "drug": {
      "current_status": "MARKETED",
      "id": 16366,
      "drug_code": 77146,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255831,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285975",
      "brand_name": "TEVA-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506005"
    },
    "created_date": "2025-04-29T18:13:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02285975",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:13:43-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR 800MG",
    "fr_drug_brand_name": "TEVA-ACYCLOVIR 800MG",
    "fr_drug_common_name": "ACYCLOVIR 800MG",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir (Acyclovir sodique)",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256131,
    "drug": {
      "current_status": "MARKETED",
      "id": 3230,
      "drug_code": 18239,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252278,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02158582",
      "brand_name": "TEVA-DICLOFENAC SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80462",
      "number_of_ais": "1",
      "ai_group_no": "0114417005"
    },
    "created_date": "2025-04-29T18:19:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02158582",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:19:58-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-DICLOFENAC SR",
    "en_drug_common_name": "DICLOFENAC SR 75MG",
    "fr_drug_brand_name": "TEVA-DICLOFENAC SR 75MG",
    "fr_drug_common_name": "DICLOFENAC SR 75MG",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256134,
    "drug": {
      "current_status": "MARKETED",
      "id": 25016,
      "drug_code": 87524,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259053,
          "ingredient": {
            "id": 2676,
            "ingredient_code": 11857,
            "en_name": "EFAVIRENZ",
            "fr_name": "Éfavirenz"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389762",
      "brand_name": "TEVA-EFAVIRENZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137031005"
    },
    "created_date": "2025-04-29T18:21:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02389762",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AG",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:22:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-EFAVIRENZ",
    "en_drug_common_name": "EFAVIRENZ 600MG",
    "fr_drug_brand_name": "TEVA-EFAVIRENZ 600MG",
    "fr_drug_common_name": "EFAVIRENZ 600MG",
    "en_ingredients": "EFAVIRENZ",
    "fr_ingredients": "Éfavirenz",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256137,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8622,
      "drug_code": 60273,
      "updated_date": "2025-12-03T01:16:52-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8324431,
          "ingredient": {
            "id": 286,
            "ingredient_code": 1204,
            "en_name": "FLUCONAZOLE",
            "fr_name": "Fluconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236978",
      "brand_name": "TEVA-FLUCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122529001"
    },
    "created_date": "2025-04-29T18:23:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02236978",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:23:27-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-FLUCONAZOLE",
    "en_drug_common_name": "FLUCONAZOLE 50MG",
    "fr_drug_brand_name": "TEVA-FLUCONAZOLE 50MG",
    "fr_drug_common_name": "FLUCONAZOLE 50MG",
    "en_ingredients": "FLUCONAZOLE",
    "fr_ingredients": "Fluconazole",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256140,
    "drug": {
      "current_status": "MARKETED",
      "id": 21838,
      "drug_code": 84213,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257807,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257806,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357038",
      "brand_name": "TEVA-VALSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240204004"
    },
    "created_date": "2025-04-29T18:24:41-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02357038",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:25:01-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "en_drug_common_name": "VALSARTAN/HCTZ 320MG/12.5MG",
    "fr_drug_brand_name": "TEVA-VALSARTAN/HCTZ 320MG/12.5MG",
    "fr_drug_common_name": "VALSARTAN/HCTZ 320MG/12.5MG",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nVALSARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nValsartan",
    "drug_strength": "12.5MG\r\n320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "pp 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256143,
    "drug": {
      "current_status": "MARKETED",
      "id": 21840,
      "drug_code": 84214,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257809,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257808,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357046",
      "brand_name": "TEVA-VALSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240204005"
    },
    "created_date": "2025-04-29T18:26:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02357046",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:26:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "en_drug_common_name": "TEVA-VALSARTAN/HCTZ 320MG/25MG",
    "fr_drug_brand_name": "TEVA-VALSARTAN/HCTZ",
    "fr_drug_common_name": "VALSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nVALSARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nValsartan",
    "drug_strength": "25MG\r\n320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "pp30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256146,
    "drug": {
      "current_status": "MARKETED",
      "id": 21778,
      "drug_code": 84178,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257770,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356643",
      "brand_name": "TEVA-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2025-04-29T18:30:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02356643",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:31:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN",
    "en_drug_common_name": "VALSARTAN 40MG",
    "fr_drug_brand_name": "TEVA-VALSARTAN",
    "fr_drug_common_name": "TEVA-VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256149,
    "drug": {
      "current_status": "MARKETED",
      "id": 21780,
      "drug_code": 84179,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257771,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356651",
      "brand_name": "TEVA-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2025-04-29T18:32:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02356651",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:32:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN",
    "en_drug_common_name": "VALSARTAN 80MG",
    "fr_drug_brand_name": "TEVA-VALSARTAN 80MG",
    "fr_drug_common_name": "VALSARTAN 80MG",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256152,
    "drug": {
      "current_status": "MARKETED",
      "id": 21782,
      "drug_code": 84180,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257772,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356678",
      "brand_name": "TEVA-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2025-04-29T18:35:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02356678",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:36:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN",
    "en_drug_common_name": "VALSARTAN 160MG",
    "fr_drug_brand_name": "TEVA-VALSARTAN 160MG",
    "fr_drug_common_name": "VALSARTAN 160MG",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256155,
    "drug": {
      "current_status": "MARKETED",
      "id": 21784,
      "drug_code": 84181,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257773,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356686",
      "brand_name": "TEVA-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2025-04-29T18:36:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02356686",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:37:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VALSARTAN",
    "en_drug_common_name": "VALSARTAN 3200MG",
    "fr_drug_brand_name": "TEVA-VALSARTAN 160MG",
    "fr_drug_common_name": "VALSARTAN 160MG",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256166,
    "drug": {
      "current_status": "MARKETED",
      "id": 25808,
      "drug_code": 88189,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259307,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396874",
      "brand_name": "TEVA-VORICONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242002"
    },
    "created_date": "2025-04-29T18:42:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02396874",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:42:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VORICONAZOLE",
    "en_drug_common_name": "VORICONAZOLE 200MG",
    "fr_drug_brand_name": "TEVA-VORICONAZOLE 200MG",
    "fr_drug_common_name": "VORICONAZOLE 200MG",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256169,
    "drug": {
      "current_status": "MARKETED",
      "id": 25806,
      "drug_code": 88187,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259306,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396866",
      "brand_name": "TEVA-VORICONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242001"
    },
    "created_date": "2025-04-29T18:43:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02396866",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "discontinuation_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2025-04-29T18:43:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VORICONAZOLE",
    "en_drug_common_name": "VORICONAZOLE 50MG",
    "fr_drug_brand_name": "TEVA-VORICONAZOLE 50MG",
    "fr_drug_common_name": "VORICONAZOLE 50MG",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 256188,
    "drug": {
      "current_status": "MARKETED",
      "id": 62394,
      "drug_code": 97437,
      "updated_date": "2025-05-15T02:37:16-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8263806,
          "ingredient": {
            "id": 18411,
            "ingredient_code": 20488,
            "en_name": "EXAMETAZIME",
            "fr_name": "Examétazime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02484048",
      "brand_name": "CERETEC",
      "brand_name_fr": "",
      "descriptor": "WITH COBALT STABILIZER SOLUTION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152612001"
    },
    "created_date": "2025-04-30T19:26:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02484048",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V09HA",
    "estimated_end_date": "2025-05-12T00:00:00-04:00",
    "actual_start_date": "2025-04-30T00:00:00-04:00",
    "actual_end_date": "2025-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-13T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CERETEC",
    "en_drug_common_name": "Kit for the Preparation of Technetium-99m Exametazime Injection",
    "fr_drug_brand_name": "Ceretec",
    "fr_drug_common_name": "Trousse pour la préparation d’injections d’examétazime au technétium Tc99m",
    "en_ingredients": "EXAMETAZIME",
    "fr_ingredients": "Examétazime",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5 unit package",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]